# eBay timeline

entity: /record/ebay.md  
id: ent_ebay  


## undated

- undated | cik | 0001065088 | valid | [clm_1EF57789A226](/claim/clm_1EF57789A226.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_35612C093FBB](/claim/clm_35612C093FBB.md)
- undated | ticker | EBAY | valid | [clm_640ED0F188F2](/claim/clm_640ED0F188F2.md)
- undated | state_of_incorporation | DE | valid | [clm_6A628CDDFA77](/claim/clm_6A628CDDFA77.md)
- undated | registrant_name | EBAY INC | valid | [clm_EFCF45606021](/claim/clm_EFCF45606021.md)
- undated | sic_industry | Services-Business Services, NEC (7389) | valid | [clm_F7384D6DE940](/claim/clm_F7384D6DE940.md)
- undated | member_of | German Association for the Digital Economy | unverified | [clm_02BA9A59DDE9](/claim/clm_02BA9A59DDE9.md)
- undated | website | https://www.ebay.es | unverified | [clm_0FD862FB7384](/claim/clm_0FD862FB7384.md)
- undated | industry | e-commerce | unverified | [clm_119AE465C172](/claim/clm_119AE465C172.md)
- undated | owner_of | Shopping.com | unverified | [clm_140D1022796C](/claim/clm_140D1022796C.md)
- undated | owner_of | Gumtree | unverified | [clm_217B87034D84](/claim/clm_217B87034D84.md)
- undated | website | https://www.ebay.de/ | unverified | [clm_24B8BBDF079E](/claim/clm_24B8BBDF079E.md)
- undated | member_of | Federal Association of City and City Marketing Germany | unverified | [clm_303187C465D7](/claim/clm_303187C465D7.md)
- undated | member_of | Berlin Partner for Business and Technology | unverified | [clm_3474475AC564](/claim/clm_3474475AC564.md)
- undated | owner_of | Epinions | unverified | [clm_3685646B10A5](/claim/clm_3685646B10A5.md)
- undated | member_of | OpenID Foundation | valid | [clm_464213702557](/claim/clm_464213702557.md)
- undated | member_of | Bundesverband E-Commerce und Versandhandel Deutschland | unverified | [clm_4D530D3D17A7](/claim/clm_4D530D3D17A7.md)
- undated | country | United States | valid | [clm_5098F48FEFAE](/claim/clm_5098F48FEFAE.md)
- undated | subsidiary | Ebay (Ireland) | unverified | [clm_51A02445F230](/claim/clm_51A02445F230.md)
- undated | member_of | FIDO Alliance | valid | [clm_555C2BDA0B0C](/claim/clm_555C2BDA0B0C.md)
- undated | member_of | American Chamber of Commerce in Germany | unverified | [clm_5D0826B60CA1](/claim/clm_5D0826B60CA1.md)
- undated | subsidiary | eBay Korea | unverified | [clm_5FA0D75F44B9](/claim/clm_5FA0D75F44B9.md)
- undated | industry | retail | unverified | [clm_629DAEED93DF](/claim/clm_629DAEED93DF.md)
- undated | website | https://www.ebay.fr/ | unverified | [clm_6656B6C4335C](/claim/clm_6656B6C4335C.md)
- undated | website | https://www.ebay.it | unverified | [clm_66C683106E79](/claim/clm_66C683106E79.md)
- undated | subsidiary | mobile.de | unverified | [clm_6DAE1521F956](/claim/clm_6DAE1521F956.md)
- undated | website | https://www.ebay.co.uk/ | unverified | [clm_70D8431DED4F](/claim/clm_70D8431DED4F.md)
- undated | member_of | bitkom | unverified | [clm_77C0D9AD96E4](/claim/clm_77C0D9AD96E4.md)
- undated | subsidiary | Qoo10.jp | valid | [clm_7AE3EEF02D61](/claim/clm_7AE3EEF02D61.md)
- undated | website | https://www.ebay.com | unverified | [clm_7B2BA02C0FE9](/claim/clm_7B2BA02C0FE9.md)
- undated | website | https://www.ebay.com.au/ | unverified | [clm_7B662B4C44E7](/claim/clm_7B662B4C44E7.md)
- undated | headquarters | San Jose | unverified | [clm_81046AD00732](/claim/clm_81046AD00732.md)
- undated | member_of | OpenAPI Initiative | valid | [clm_82D7EC5F53B5](/claim/clm_82D7EC5F53B5.md)
- undated | founder | Pierre Omidyar | unverified | [clm_8B3E47997713](/claim/clm_8B3E47997713.md)
- undated | website | https://www.ebayinc.com/ | unverified | [clm_B33C723388C8](/claim/clm_B33C723388C8.md)
- undated | owner_of | half.com | unverified | [clm_B44F72BFC75C](/claim/clm_B44F72BFC75C.md)
- undated | member_of | medianet berlinbrandenburg | unverified | [clm_B7221DF3890A](/claim/clm_B7221DF3890A.md)
- undated | member_of | [Linux Foundation](/record/linux-foundation.md) | valid | [clm_C90CB5557177](/claim/clm_C90CB5557177.md)
- undated | legal_form | corporation | unverified | [clm_CC624BBA9F42](/claim/clm_CC624BBA9F42.md)
- undated | member_of | Computer & Communications Industry Association | valid | [clm_EF426ACBB164](/claim/clm_EF426ACBB164.md)
- undated | member_of | Internet Association | valid | [clm_F360393BA0C6](/claim/clm_F360393BA0C6.md)
- undated | owner_of | Den Blå Avis | unverified | [clm_FAB04396BD0A](/claim/clm_FAB04396BD0A.md)
- undated | subsidiary | StubHub | unverified | [clm_FDBA82D3A39A](/claim/clm_FDBA82D3A39A.md)

## 1995

- 1995-09-01 to 1997-09-01 | official_name | AuctionWeb | superseded | [clm_4F0C502AB641](/claim/clm_4F0C502AB641.md)
- 1995-09-03 | founded | 1995-09-03 | unverified | [clm_EC012DDEFA75](/claim/clm_EC012DDEFA75.md)

## 1997

- 1997-09-01 | official_name | eBay Inc. | valid | [clm_2A15C068480D](/claim/clm_2A15C068480D.md)

## 1998

- 1998-01-01 to 2008-01-01 | ceo | Meg Whitman | superseded | [clm_8C2CC966D13D](/claim/clm_8C2CC966D13D.md)
- 1998-09-24 | listed_on | Nasdaq | valid | [clm_31588929CB04](/claim/clm_31588929CB04.md)

## 2002

- 2002-10-01 to 2015-07-01 | subsidiary | [PayPal](/record/paypal.md) | superseded | [clm_6419C7A867AE](/claim/clm_6419C7A867AE.md)
- 2002-10-01 to 2015-07-01 | owner_of | [PayPal](/record/paypal.md) | superseded | [clm_9058C25AF418](/claim/clm_9058C25AF418.md)

## 2005

- 2005-09-01 to 2009-11-01 | subsidiary | Skype Technologies | superseded | [clm_C0FBB9EAE4A3](/claim/clm_C0FBB9EAE4A3.md)

## 2006

- 2006-12-31 to 2007-12-31 | cash_and_equivalents | 2,662,792,000 United States dollar | superseded | [clm_CE08C430E14E](/claim/clm_CE08C430E14E.md)

## 2007

- 2007-05-01 to 2009-04-13 | subsidiary | StumbleUpon | superseded | [clm_E6E8514733E2](/claim/clm_E6E8514733E2.md)
- 2007-12-31 to 2008-12-31 | revenue | 7,672,329,000 United States dollar | superseded | [clm_02F78C48216E](/claim/clm_02F78C48216E.md)
- 2007-12-31 to 2008-12-31 | net_income | 348,251,000 United States dollar | superseded | [clm_05E2B3801E02](/claim/clm_05E2B3801E02.md)
- 2007-12-31 to 2008-12-31 | total_equity | 11,704,602,000 United States dollar | superseded | [clm_2F63A2C7EB74](/claim/clm_2F63A2C7EB74.md)
- 2007-12-31 to 2008-12-31 | operating_income | 613,180,000 United States dollar | superseded | [clm_9656ABCD9360](/claim/clm_9656ABCD9360.md)
- 2007-12-31 to 2008-12-31 | research_and_development | 619,727,000 United States dollar | superseded | [clm_CC9BD1C1C499](/claim/clm_CC9BD1C1C499.md)
- 2007-12-31 to 2008-06-30 | cash_and_equivalents | 4,221,191,000 United States dollar | superseded | [clm_D5E94816085C](/claim/clm_D5E94816085C.md)

## 2008

- 2008-01-01 to 2015-01-01 | ceo | John Donahoe | superseded | [clm_8415658C67A9](/claim/clm_8415658C67A9.md)
- 2008-02-03 | x_username | eBayNewsroom | unverified | [clm_F76E4455ECB4](/claim/clm_F76E4455ECB4.md)
- 2008-06-30 to 2008-09-30 | quarterly_research_and_development | 186,791,000 United States dollar | superseded | [clm_3BA373432D79](/claim/clm_3BA373432D79.md)
- 2008-06-30 to 2008-09-30 | quarterly_operating_income | 545,367,000 United States dollar | superseded | [clm_7359A13A9361](/claim/clm_7359A13A9361.md)
- 2008-06-30 to 2008-09-30 | cash_and_equivalents | 3,696,028,000 United States dollar | superseded | [clm_9557310A11B1](/claim/clm_9557310A11B1.md)
- 2008-06-30 to 2008-09-30 | quarterly_net_income | 460,345,000 United States dollar | superseded | [clm_F3ED953B77EF](/claim/clm_F3ED953B77EF.md)
- 2008-07-15 | x_username | eBayDE_News | unverified | [clm_0901DAB28CA3](/claim/clm_0901DAB28CA3.md)
- 2008-09-30 to 2009-03-31 | quarterly_net_income | 492,219,000 United States dollar | superseded | [clm_2741DD81FBA5](/claim/clm_2741DD81FBA5.md)
- 2008-09-30 to 2009-03-31 | quarterly_research_and_development | 190,842,000 United States dollar | superseded | [clm_74FE987F6267](/claim/clm_74FE987F6267.md)
- 2008-09-30 to 2008-12-31 | cash_and_equivalents | 3,342,717,000 United States dollar | superseded | [clm_F33814A81AE4](/claim/clm_F33814A81AE4.md)
- 2008-09-30 to 2009-03-31 | quarterly_operating_income | 524,075,000 United States dollar | superseded | [clm_F925A021F9A6](/claim/clm_F925A021F9A6.md)
- 2008-12-31 to 2009-12-31 | operating_income | 2,075,682,000 United States dollar | superseded | [clm_072CFAAEA52B](/claim/clm_072CFAAEA52B.md)
- 2008-12-31 to 2009-12-31 | revenue | 8,541,261,000 United States dollar | superseded | [clm_342B5C2AC4EF](/claim/clm_342B5C2AC4EF.md)
- 2008-12-31 to 2009-06-30 | total_assets | 15,592,439,000 United States dollar | superseded | [clm_7267A921FB28](/claim/clm_7267A921FB28.md)
- 2008-12-31 to 2009-03-31 | cash_and_equivalents | 3,188,928,000 United States dollar | superseded | [clm_784A3A7219FB](/claim/clm_784A3A7219FB.md)
- 2008-12-31 to 2009-06-30 | total_equity | 11,083,858,000 United States dollar | superseded | [clm_BB99898D4FF8](/claim/clm_BB99898D4FF8.md)
- 2008-12-31 to 2009-12-31 | net_income | 1,779,474,000 United States dollar | superseded | [clm_C2DEA5CAFB3B](/claim/clm_C2DEA5CAFB3B.md)
- 2008-12-31 to 2009-12-31 | research_and_development | 725,600,000 United States dollar | superseded | [clm_FB8D4A143FA2](/claim/clm_FB8D4A143FA2.md)

## 2009

- 2009-01-29 | x_username | eBay | unverified | [clm_4932749F1D04](/claim/clm_4932749F1D04.md)
- 2009-03-14 | x_username | eBayAU | unverified | [clm_1C8F5EEB488D](/claim/clm_1C8F5EEB488D.md)
- 2009-03-31 to 2009-06-30 | cash_and_equivalents | 3,057,159,000 United States dollar | superseded | [clm_34B802A08B14](/claim/clm_34B802A08B14.md)
- 2009-03-31 to 2009-06-30 | quarterly_operating_income | 422,764,000 United States dollar | superseded | [clm_99A1557AEBAC](/claim/clm_99A1557AEBAC.md)
- 2009-03-31 to 2009-06-30 | quarterly_research_and_development | 201,516,000 United States dollar | superseded | [clm_B47B0A7C2ED9](/claim/clm_B47B0A7C2ED9.md)
- 2009-03-31 to 2009-06-30 | quarterly_net_income | 357,113,000 United States dollar | superseded | [clm_EBF6D2B67D64](/claim/clm_EBF6D2B67D64.md)
- 2009-04-20 | x_username | eBay_UK | unverified | [clm_3F191F5C752C](/claim/clm_3F191F5C752C.md)
- 2009-06-15 | x_username | eBay4CharityUS | unverified | [clm_6C1FDF9086CD](/claim/clm_6C1FDF9086CD.md)
- 2009-06-23 | x_username | ebaymainstreet | unverified | [clm_1CD98BBAA62D](/claim/clm_1CD98BBAA62D.md)
- 2009-06-30 to 2009-09-30 | quarterly_research_and_development | 198,403,000 United States dollar | superseded | [clm_20EA86FC32CD](/claim/clm_20EA86FC32CD.md)
- 2009-06-30 to 2009-09-30 | total_equity | 11,921,572,000 United States dollar | superseded | [clm_5ADD5812423E](/claim/clm_5ADD5812423E.md)
- 2009-06-30 to 2009-09-30 | quarterly_net_income | 327,342,000 United States dollar | superseded | [clm_6FCDF96D4FE4](/claim/clm_6FCDF96D4FE4.md)
- 2009-06-30 to 2009-09-30 | total_assets | 16,566,289,000 United States dollar | superseded | [clm_95668ECCB5E7](/claim/clm_95668ECCB5E7.md)
- 2009-06-30 to 2009-09-30 | cash_and_equivalents | 2,573,617,000 United States dollar | superseded | [clm_BFBC26BE80BD](/claim/clm_BFBC26BE80BD.md)
- 2009-06-30 to 2009-09-30 | quarterly_operating_income | 411,689,000 United States dollar | superseded | [clm_FB38F7424D91](/claim/clm_FB38F7424D91.md)
- 2009-07-21 to 2009-10-14 | shares_outstanding | 1,290,403,139 shares | superseded | [clm_8A454A3EC551](/claim/clm_8A454A3EC551.md)
- 2009-08-25 | x_username | eBayDealsCanada | unverified | [clm_45DA0EE75FE9](/claim/clm_45DA0EE75FE9.md)
- 2009-09-30 to 2009-12-31 | total_equity | 12,751,167,000 United States dollar | superseded | [clm_05A0F08DBBE2](/claim/clm_05A0F08DBBE2.md)
- 2009-09-30 to 2010-03-31 | quarterly_net_income | 349,736,000 United States dollar | superseded | [clm_1648B1C53804](/claim/clm_1648B1C53804.md)
- 2009-09-30 to 2010-03-31 | quarterly_operating_income | 442,941,000 United States dollar | superseded | [clm_272D70D0B504](/claim/clm_272D70D0B504.md)
- 2009-09-30 to 2009-12-31 | total_assets | 17,356,372,000 United States dollar | superseded | [clm_768B0237DAB5](/claim/clm_768B0237DAB5.md)
- 2009-09-30 to 2010-03-31 | quarterly_revenue | 2,237,852,000 United States dollar | superseded | [clm_8E57F9086F86](/claim/clm_8E57F9086F86.md)
- 2009-09-30 to 2010-03-31 | quarterly_research_and_development | 205,207,000 United States dollar | superseded | [clm_B6AC8FF24D13](/claim/clm_B6AC8FF24D13.md)
- 2009-09-30 to 2009-12-31 | cash_and_equivalents | 2,557,859,000 United States dollar | superseded | [clm_B824300E1355](/claim/clm_B824300E1355.md)
- 2009-10-14 to 2010-02-12 | shares_outstanding | 1,292,961,679 shares | superseded | [clm_B76328C45746](/claim/clm_B76328C45746.md)
- 2009-12-31 to 2010-03-31 | total_assets | 18,408,320,000 United States dollar | superseded | [clm_18892A89A1FD](/claim/clm_18892A89A1FD.md)
- 2009-12-31 to 2010-12-31 | research_and_development | 803,070,000 United States dollar | superseded | [clm_5A9C5536248D](/claim/clm_5A9C5536248D.md)
- 2009-12-31 to 2010-03-31 | cash_and_equivalents | 3,999,818,000 United States dollar | superseded | [clm_6CC6F82F79BF](/claim/clm_6CC6F82F79BF.md)
- 2009-12-31 to 2010-03-31 | total_equity | 13,787,648,000 United States dollar | superseded | [clm_8139ADAE272E](/claim/clm_8139ADAE272E.md)
- 2009-12-31 to 2010-12-31 | operating_income | 1,456,766,000 United States dollar | superseded | [clm_B14214E7102C](/claim/clm_B14214E7102C.md)
- 2009-12-31 to 2010-12-31 | net_income | 2,389,097,000 United States dollar | superseded | [clm_B870D62091E4](/claim/clm_B870D62091E4.md)
- 2009-12-31 to 2010-12-31 | revenue | 8,727,362,000 United States dollar | superseded | [clm_C64EF499A6E4](/claim/clm_C64EF499A6E4.md)

## 2010

- 2010-02-12 to 2010-04-14 | shares_outstanding | 1,299,006,884 shares | superseded | [clm_B87884DC6D09](/claim/clm_B87884DC6D09.md)
- 2010-03-31 to 2010-06-30 | total_equity | 14,125,109,000 United States dollar | superseded | [clm_47617E41E742](/claim/clm_47617E41E742.md)
- 2010-03-31 to 2010-06-30 | quarterly_revenue | 2,196,057,000 United States dollar | superseded | [clm_4D8D39D7F3BD](/claim/clm_4D8D39D7F3BD.md)
- 2010-03-31 to 2010-06-30 | quarterly_net_income | 397,653,000 United States dollar | superseded | [clm_5E3D8639429F](/claim/clm_5E3D8639429F.md)
- 2010-03-31 to 2010-06-30 | cash_and_equivalents | 3,593,003,000 United States dollar | superseded | [clm_9F1098BFF527](/claim/clm_9F1098BFF527.md)
- 2010-03-31 to 2010-06-30 | total_assets | 18,690,178,000 United States dollar | superseded | [clm_B5842FB0F3A6](/claim/clm_B5842FB0F3A6.md)
- 2010-03-31 to 2010-06-30 | quarterly_research_and_development | 210,139,000 United States dollar | superseded | [clm_E583199A3D94](/claim/clm_E583199A3D94.md)
- 2010-03-31 to 2010-06-30 | quarterly_operating_income | 488,609,000 United States dollar | superseded | [clm_E6B18A94133A](/claim/clm_E6B18A94133A.md)
- 2010-04-14 to 2010-07-15 | shares_outstanding | 1,306,969,862 shares | superseded | [clm_6D65B1287661](/claim/clm_6D65B1287661.md)
- 2010-06-30 to 2010-09-30 | quarterly_net_income | 412,192,000 United States dollar | superseded | [clm_557A034785FE](/claim/clm_557A034785FE.md)
- 2010-06-30 to 2010-09-30 | quarterly_research_and_development | 225,317,000 United States dollar | superseded | [clm_7E25D1D28B68](/claim/clm_7E25D1D28B68.md)
- 2010-06-30 to 2010-09-30 | cash_and_equivalents | 4,037,442,000 United States dollar | superseded | [clm_8408BEC159E9](/claim/clm_8408BEC159E9.md)
- 2010-06-30 to 2010-09-30 | quarterly_operating_income | 484,565,000 United States dollar | superseded | [clm_91AE3665B1D6](/claim/clm_91AE3665B1D6.md)
- 2010-06-30 to 2010-09-30 | quarterly_revenue | 2,215,379,000 United States dollar | superseded | [clm_B70297F4F211](/claim/clm_B70297F4F211.md)
- 2010-06-30 to 2010-09-30 | total_equity | 14,169,291,000 United States dollar | superseded | [clm_DE876A82E9E2](/claim/clm_DE876A82E9E2.md)
- 2010-06-30 to 2010-09-30 | total_assets | 18,747,584,000 United States dollar | superseded | [clm_F7A064B2C9D9](/claim/clm_F7A064B2C9D9.md)
- 2010-07-15 to 2010-10-14 | shares_outstanding | 1,312,154,640 shares | superseded | [clm_E5C239FDA2FD](/claim/clm_E5C239FDA2FD.md)
- 2010-09-08 | x_username | ebaytech | unverified | [clm_5C5A82C62C9E](/claim/clm_5C5A82C62C9E.md)
- 2010-09-30 to 2010-12-31 | total_equity | 15,033,952,000 United States dollar | superseded | [clm_1B715A3082BB](/claim/clm_1B715A3082BB.md)
- 2010-09-30 to 2011-03-31 | quarterly_operating_income | 490,176,000 United States dollar | superseded | [clm_4DDA46222C35](/claim/clm_4DDA46222C35.md)
- 2010-09-30 to 2011-03-31 | quarterly_revenue | 2,249,488,000 United States dollar | superseded | [clm_7844D3233D0B](/claim/clm_7844D3233D0B.md)
- 2010-09-30 to 2010-12-31 | cash_and_equivalents | 4,180,907,000 United States dollar | superseded | [clm_9B63A823062B](/claim/clm_9B63A823062B.md)
- 2010-09-30 to 2010-12-31 | total_assets | 19,948,062,000 United States dollar | superseded | [clm_C0B5793D83AE](/claim/clm_C0B5793D83AE.md)
- 2010-09-30 to 2011-03-31 | quarterly_net_income | 431,929,000 United States dollar | superseded | [clm_F2D971F365CB](/claim/clm_F2D971F365CB.md)
- 2010-09-30 to 2011-03-31 | quarterly_research_and_development | 226,803,000 United States dollar | superseded | [clm_F37C3AB3FCBD](/claim/clm_F37C3AB3FCBD.md)
- 2010-10-14 to 2011-01-27 | shares_outstanding | 1,303,738,840 shares | superseded | [clm_C8E2E1460AB9](/claim/clm_C8E2E1460AB9.md)
- 2010-12-31 to 2011-12-31 | revenue | 9,156,274,000 United States dollar | superseded | [clm_04C84E8DF2FB](/claim/clm_04C84E8DF2FB.md)
- 2010-12-31 to 2011-03-31 | total_equity | 15,302,179,000 United States dollar | superseded | [clm_0FA82F2CB96B](/claim/clm_0FA82F2CB96B.md)
- 2010-12-31 to 2011-03-31 | cash_and_equivalents | 5,577,411,000 United States dollar | superseded | [clm_30AFB9A11877](/claim/clm_30AFB9A11877.md)
- 2010-12-31 to 2011-03-31 | total_assets | 22,003,762,000 United States dollar | superseded | [clm_55519044588E](/claim/clm_55519044588E.md)
- 2010-12-31 to 2011-12-31 | net_income | 1,800,961,000 United States dollar | superseded | [clm_5D571C57C243](/claim/clm_5D571C57C243.md)
- 2010-12-31 to 2011-12-31 | operating_income | 2,053,571,000 United States dollar | superseded | [clm_C8045E0E5ECE](/claim/clm_C8045E0E5ECE.md)
- 2010-12-31 to 2011-12-31 | research_and_development | 908,434,000 United States dollar | superseded | [clm_D7FBD0DC9B0E](/claim/clm_D7FBD0DC9B0E.md)

## 2011

- 2011-01-27 to 2011-04-25 | shares_outstanding | 1,298,369,992 shares | superseded | [clm_8C969302F698](/claim/clm_8C969302F698.md)
- 2011-03-31 to 2011-06-30 | quarterly_operating_income | 564,654,000 United States dollar | superseded | [clm_2CD7DA647E5A](/claim/clm_2CD7DA647E5A.md)
- 2011-03-31 to 2011-06-30 | quarterly_research_and_development | 274,782,000 United States dollar | superseded | [clm_38B6E9159C8A](/claim/clm_38B6E9159C8A.md)
- 2011-03-31 to 2011-06-30 | cash_and_equivalents | 5,464,582,000 United States dollar | superseded | [clm_5AB0FB1169C0](/claim/clm_5AB0FB1169C0.md)
- 2011-03-31 to 2011-06-30 | quarterly_net_income | 475,865,000 United States dollar | superseded | [clm_6DE76854E0DD](/claim/clm_6DE76854E0DD.md)
- 2011-03-31 to 2011-06-30 | total_assets | 23,004,860,000 United States dollar | superseded | [clm_6F64281CEA81](/claim/clm_6F64281CEA81.md)
- 2011-03-31 to 2011-06-30 | quarterly_revenue | 2,545,609,000 United States dollar | superseded | [clm_C9590C181D2F](/claim/clm_C9590C181D2F.md)
- 2011-03-31 to 2011-06-30 | total_equity | 15,944,413,000 United States dollar | superseded | [clm_D591D9499369](/claim/clm_D591D9499369.md)
- 2011-04-04 | x_username | eBayCanada | unverified | [clm_6FD1E85FCF0B](/claim/clm_6FD1E85FCF0B.md)
- 2011-04-25 to 2011-07-18 | shares_outstanding | 1,297,898,817 shares | superseded | [clm_DDB5B16192D2](/claim/clm_DDB5B16192D2.md)
- 2011-06-30 to 2011-09-30 | cash_and_equivalents | 3,265,826,000 United States dollar | superseded | [clm_117B56D4F2BA](/claim/clm_117B56D4F2BA.md)
- 2011-06-30 to 2011-09-30 | quarterly_operating_income | 518,899,000 United States dollar | superseded | [clm_150F6713C683](/claim/clm_150F6713C683.md)
- 2011-06-30 to 2011-09-30 | total_equity | 16,209,882,000 United States dollar | superseded | [clm_2DEC7D274752](/claim/clm_2DEC7D274752.md)
- 2011-06-30 to 2011-09-30 | quarterly_research_and_development | 297,035,000 United States dollar | superseded | [clm_4AB7AC717CDD](/claim/clm_4AB7AC717CDD.md)
- 2011-06-30 to 2011-09-30 | quarterly_net_income | 283,407,000 United States dollar | superseded | [clm_5BDF57980F3A](/claim/clm_5BDF57980F3A.md)
- 2011-06-30 to 2011-09-30 | quarterly_revenue | 2,760,274,000 United States dollar | superseded | [clm_B69A6E34F370](/claim/clm_B69A6E34F370.md)
- 2011-06-30 to 2011-09-30 | total_assets | 24,833,954,000 United States dollar | superseded | [clm_BC6BE0E22FEC](/claim/clm_BC6BE0E22FEC.md)
- 2011-07-18 to 2011-10-17 | shares_outstanding | 1,288,759,170 shares | superseded | [clm_F5C2A97330F6](/claim/clm_F5C2A97330F6.md)
- 2011-09-30 to 2012-03-31 | quarterly_operating_income | 536,821,000 United States dollar | superseded | [clm_02C8755A8B34](/claim/clm_02C8755A8B34.md)
- 2011-09-30 to 2011-12-31 | total_assets | 24,900,537,000 United States dollar | superseded | [clm_4D779DA9D4FE](/claim/clm_4D779DA9D4FE.md)
- 2011-09-30 to 2012-03-31 | quarterly_research_and_development | 318,902,000 United States dollar | superseded | [clm_75DB082E91B3](/claim/clm_75DB082E91B3.md)
- 2011-09-30 to 2012-03-31 | quarterly_revenue | 2,965,761,000 United States dollar | superseded | [clm_92E7A77C2994](/claim/clm_92E7A77C2994.md)
- 2011-09-30 to 2011-12-31 | cash_and_equivalents | 2,998,950,000 United States dollar | superseded | [clm_CDF039280B97](/claim/clm_CDF039280B97.md)
- 2011-09-30 to 2012-03-31 | quarterly_net_income | 490,503,000 United States dollar | superseded | [clm_F2C8B550B5E7](/claim/clm_F2C8B550B5E7.md)
- 2011-09-30 to 2011-12-31 | total_equity | 16,165,326,000 United States dollar | superseded | [clm_FBCD956E2D4C](/claim/clm_FBCD956E2D4C.md)
- 2011-10-17 to 2012-01-23 | shares_outstanding | 1,290,934,293 shares | superseded | [clm_FECFA1863E76](/claim/clm_FECFA1863E76.md)
- 2011-12-06 | x_username | AskeBay | unverified | [clm_2D7D7D0DECFA](/claim/clm_2D7D7D0DECFA.md)
- 2011-12-31 to 2012-12-31 | net_income | 3,229,387,000 United States dollar | superseded | [clm_00AE14D7376F](/claim/clm_00AE14D7376F.md)
- 2011-12-31 to 2012-03-31 | cash_and_equivalents | 4,691,101,000 United States dollar | superseded | [clm_19B6990DE33F](/claim/clm_19B6990DE33F.md)
- 2011-12-31 to 2012-03-31 | total_assets | 27,320,218,000 United States dollar | superseded | [clm_3C5E98593237](/claim/clm_3C5E98593237.md)
- 2011-12-31 to 2012-12-31 | operating_income | 2,373,489,000 United States dollar | superseded | [clm_56A1C596E01D](/claim/clm_56A1C596E01D.md)
- 2011-12-31 to 2012-12-31 | research_and_development | 1,235,171,000 United States dollar | superseded | [clm_90C20AB75303](/claim/clm_90C20AB75303.md)
- 2011-12-31 to 2012-12-31 | revenue | 11,651,654,000 United States dollar | superseded | [clm_960373908387](/claim/clm_960373908387.md)
- 2011-12-31 to 2012-03-31 | total_equity | 17,929,879,000 United States dollar | superseded | [clm_C84E3E5BE08A](/claim/clm_C84E3E5BE08A.md)

## 2012

- 2012-01-23 to 2012-04-16 | shares_outstanding | 1,286,914,976 shares | superseded | [clm_AE0837B37852](/claim/clm_AE0837B37852.md)
- 2012-03-31 to 2012-06-30 | quarterly_operating_income | 653,000,000 United States dollar | superseded | [clm_5D0110D97828](/claim/clm_5D0110D97828.md)
- 2012-03-31 to 2012-06-30 | quarterly_research_and_development | 374,000,000 United States dollar | superseded | [clm_8118A82C28B3](/claim/clm_8118A82C28B3.md)
- 2012-03-31 to 2012-06-30 | total_assets | 28,207,000,000 United States dollar | superseded | [clm_819A54C724C5](/claim/clm_819A54C724C5.md)
- 2012-03-31 to 2012-06-30 | cash_and_equivalents | 4,164,000,000 United States dollar | superseded | [clm_8A5BF1D27D12](/claim/clm_8A5BF1D27D12.md)
- 2012-03-31 to 2012-06-30 | quarterly_revenue | 3,277,000,000 United States dollar | superseded | [clm_8FB774564CB7](/claim/clm_8FB774564CB7.md)
- 2012-03-31 to 2012-06-30 | total_equity | 18,709,000,000 United States dollar | superseded | [clm_9992B0B4EE1F](/claim/clm_9992B0B4EE1F.md)
- 2012-03-31 to 2012-06-30 | quarterly_net_income | 570,000,000 United States dollar | superseded | [clm_DF20AB5CFCF2](/claim/clm_DF20AB5CFCF2.md)
- 2012-04-16 to 2012-07-16 | shares_outstanding | 1,291,228,450 shares | superseded | [clm_354399AB8F92](/claim/clm_354399AB8F92.md)
- 2012-06-30 to 2012-09-30 | quarterly_operating_income | 695,000,000 United States dollar | superseded | [clm_09B48D7834C0](/claim/clm_09B48D7834C0.md)
- 2012-06-30 to 2012-09-30 | cash_and_equivalents | 4,038,000,000 United States dollar | superseded | [clm_1100640A71CB](/claim/clm_1100640A71CB.md)
- 2012-06-30 to 2012-09-30 | quarterly_revenue | 3,398,000,000 United States dollar | superseded | [clm_23186077C1DC](/claim/clm_23186077C1DC.md)
- 2012-06-30 to 2012-09-30 | total_assets | 28,258,000,000 United States dollar | superseded | [clm_5A12B05DEF08](/claim/clm_5A12B05DEF08.md)
- 2012-06-30 to 2012-09-30 | quarterly_research_and_development | 394,000,000 United States dollar | superseded | [clm_65456C44B93A](/claim/clm_65456C44B93A.md)
- 2012-06-30 to 2012-09-30 | total_equity | 18,912,000,000 United States dollar | superseded | [clm_7F01CB6D99C7](/claim/clm_7F01CB6D99C7.md)
- 2012-06-30 to 2012-09-30 | quarterly_net_income | 692,000,000 United States dollar | superseded | [clm_89B1AB8A8071](/claim/clm_89B1AB8A8071.md)
- 2012-07-16 to 2012-10-15 | shares_outstanding | 1,288,670,071 shares | superseded | [clm_DA2057391436](/claim/clm_DA2057391436.md)
- 2012-09-30 to 2013-03-31 | quarterly_research_and_development | 389,000,000 United States dollar | superseded | [clm_0CB2B11574EF](/claim/clm_0CB2B11574EF.md)
- 2012-09-30 to 2013-03-31 | quarterly_operating_income | 667,000,000 United States dollar | superseded | [clm_24EA821E14B1](/claim/clm_24EA821E14B1.md)
- 2012-09-30 to 2013-03-31 | quarterly_revenue | 3,404,000,000 United States dollar | superseded | [clm_26F89E96F425](/claim/clm_26F89E96F425.md)
- 2012-09-30 to 2012-12-31 | total_equity | 19,913,000,000 United States dollar | superseded | [clm_2B05C373A22B](/claim/clm_2B05C373A22B.md)
- 2012-09-30 to 2012-12-31 | total_assets | 32,502,000,000 United States dollar | superseded | [clm_39D5DEF8FB5C](/claim/clm_39D5DEF8FB5C.md)
- 2012-09-30 to 2012-12-31 | cash_and_equivalents | 7,331,000,000 United States dollar | superseded | [clm_6D44ED24C333](/claim/clm_6D44ED24C333.md)
- 2012-09-30 to 2013-03-31 | quarterly_net_income | 597,000,000 United States dollar | superseded | [clm_BEC1DE46B323](/claim/clm_BEC1DE46B323.md)
- 2012-10-15 to 2013-01-28 | shares_outstanding | 1,293,985,406 shares | superseded | [clm_0CFF2359B35B](/claim/clm_0CFF2359B35B.md)
- 2012-12-31 to 2013-12-31 | operating_income | 2,888,000,000 United States dollar | superseded | [clm_0144FF2A83B2](/claim/clm_0144FF2A83B2.md)
- 2012-12-31 to 2013-03-31 | cash_and_equivalents | 6,817,000,000 United States dollar | superseded | [clm_015C0EA3D14E](/claim/clm_015C0EA3D14E.md)
- 2012-12-31 to 2013-03-31 | total_equity | 20,865,000,000 United States dollar | superseded | [clm_0E0F13F43A30](/claim/clm_0E0F13F43A30.md)
- 2012-12-31 to 2013-12-31 | net_income | 1,931,000,000 United States dollar | superseded | [clm_10ED1F51B051](/claim/clm_10ED1F51B051.md)
- 2012-12-31 to 2013-12-31 | revenue | 14,072,000,000 United States dollar | superseded | [clm_7B48E53875EE](/claim/clm_7B48E53875EE.md)
- 2012-12-31 to 2013-12-31 | research_and_development | 1,573,000,000 United States dollar | superseded | [clm_8F0D26A0C6FB](/claim/clm_8F0D26A0C6FB.md)
- 2012-12-31 to 2013-12-31 | operating_income | 2,165,000,000 United States dollar | superseded | [clm_CB30A6F7AE93](/claim/clm_CB30A6F7AE93.md)
- 2012-12-31 to 2013-03-31 | total_assets | 37,074,000,000 United States dollar | superseded | [clm_E27B8E826128](/claim/clm_E27B8E826128.md)
- 2012-12-31 to 2013-12-31 | revenue | 7,371,000,000 United States dollar | superseded | [clm_E6B7BADCB994](/claim/clm_E6B7BADCB994.md)
- 2012-12-31 to 2013-12-31 | net_income | 2,609,000,000 United States dollar | superseded | [clm_F42213AB62C1](/claim/clm_F42213AB62C1.md)

## 2013

- 2013-01-28 to 2013-04-15 | shares_outstanding | 1,296,512,321 shares | superseded | [clm_5AF5B3EF3496](/claim/clm_5AF5B3EF3496.md)
- 2013-03-31 to 2013-06-30 | total_assets | 38,000,000,000 United States dollar | superseded | [clm_299EA4063794](/claim/clm_299EA4063794.md)
- 2013-03-31 to 2013-06-30 | total_equity | 21,112,000,000 United States dollar | superseded | [clm_2E8827880534](/claim/clm_2E8827880534.md)
- 2013-03-31 to 2013-06-30 | quarterly_net_income | 677,000,000 United States dollar | superseded | [clm_62BA2E2A572E](/claim/clm_62BA2E2A572E.md)
- 2013-03-31 to 2013-06-30 | quarterly_research_and_development | 434,000,000 United States dollar | superseded | [clm_BA8655AD11C4](/claim/clm_BA8655AD11C4.md)
- 2013-03-31 to 2013-06-30 | cash_and_equivalents | 6,530,000,000 United States dollar | superseded | [clm_C2048E03BF3F](/claim/clm_C2048E03BF3F.md)
- 2013-03-31 to 2013-06-30 | quarterly_operating_income | 800,000,000 United States dollar | superseded | [clm_C453C31D4B18](/claim/clm_C453C31D4B18.md)
- 2013-03-31 to 2013-06-30 | quarterly_revenue | 3,748,000,000 United States dollar | superseded | [clm_E1089633870C](/claim/clm_E1089633870C.md)
- 2013-04-15 to 2013-07-15 | shares_outstanding | 1,297,789,554 shares | superseded | [clm_A709F61C1326](/claim/clm_A709F61C1326.md)
- 2013-06-30 to 2013-09-30 | cash_and_equivalents | 6,855,000,000 United States dollar | superseded | [clm_5F48F036780F](/claim/clm_5F48F036780F.md)
- 2013-06-30 to 2013-09-30 | quarterly_revenue | 3,877,000,000 United States dollar | superseded | [clm_8C29F6B300C8](/claim/clm_8C29F6B300C8.md)
- 2013-06-30 to 2013-09-30 | total_equity | 21,651,000,000 United States dollar | superseded | [clm_A23D802885FE](/claim/clm_A23D802885FE.md)
- 2013-06-30 to 2013-09-30 | quarterly_net_income | 640,000,000 United States dollar | superseded | [clm_C7CBD6BD8D49](/claim/clm_C7CBD6BD8D49.md)
- 2013-06-30 to 2013-09-30 | quarterly_operating_income | 750,000,000 United States dollar | superseded | [clm_CDD55EF52E18](/claim/clm_CDD55EF52E18.md)
- 2013-06-30 to 2013-09-30 | quarterly_research_and_development | 451,000,000 United States dollar | superseded | [clm_D2F22B947A3D](/claim/clm_D2F22B947A3D.md)
- 2013-06-30 to 2013-09-30 | total_assets | 38,550,000,000 United States dollar | superseded | [clm_F918B2A9C1D8](/claim/clm_F918B2A9C1D8.md)
- 2013-07-15 to 2013-10-14 | shares_outstanding | 1,294,532,392 shares | superseded | [clm_5196C16C3E3D](/claim/clm_5196C16C3E3D.md)
- 2013-08-20 | x_username | eBayForBusiness | unverified | [clm_D9CADD8DF16B](/claim/clm_D9CADD8DF16B.md)
- 2013-09-30 to 2014-03-31 | quarterly_revenue | 3,892,000,000 United States dollar | superseded | [clm_04B8E08CB301](/claim/clm_04B8E08CB301.md)
- 2013-09-30 to 2013-12-31 | total_assets | 40,067,000,000 United States dollar | superseded | [clm_30EA8C2F5AB6](/claim/clm_30EA8C2F5AB6.md)
- 2013-09-30 to 2014-03-31 | quarterly_net_income | 689,000,000 United States dollar | superseded | [clm_6ABD191CD6DA](/claim/clm_6ABD191CD6DA.md)
- 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 433,000,000 United States dollar | superseded | [clm_6EFF1397E564](/claim/clm_6EFF1397E564.md)
- 2013-09-30 to 2014-03-31 | quarterly_operating_income | 799,000,000 United States dollar | superseded | [clm_960595EFE29B](/claim/clm_960595EFE29B.md)
- 2013-09-30 to 2013-12-31 | total_equity | 22,767,000,000 United States dollar | superseded | [clm_AE8EA45064A4](/claim/clm_AE8EA45064A4.md)
- 2013-09-30 to 2013-12-31 | cash_and_equivalents | 5,280,000,000 United States dollar | superseded | [clm_E360BCF3CB56](/claim/clm_E360BCF3CB56.md)
- 2013-10-14 to 2014-01-24 | shares_outstanding | 1,294,597,889 shares | superseded | [clm_E3F2C93D029C](/claim/clm_E3F2C93D029C.md)
- 2013-12-31 to 2014-12-31 | net_income | 2,067,000,000 United States dollar | superseded | [clm_038594E6464D](/claim/clm_038594E6464D.md)
- 2013-12-31 to 2014-03-31 | total_assets | 41,488,000,000 United States dollar | superseded | [clm_139054DC79E3](/claim/clm_139054DC79E3.md)
- 2013-12-31 to 2014-12-31 | revenue | 8,257,000,000 United States dollar | superseded | [clm_1D7B01360D2B](/claim/clm_1D7B01360D2B.md)
- 2013-12-31 to 2014-03-31 | total_equity | 23,647,000,000 United States dollar | superseded | [clm_452BE01B08FA](/claim/clm_452BE01B08FA.md)
- 2013-12-31 to 2014-12-31 | operating_income | 2,454,000,000 United States dollar | superseded | [clm_8A0A74E087B4](/claim/clm_8A0A74E087B4.md)
- 2013-12-31 to 2014-12-31 | operating_income | 3,371,000,000 United States dollar | superseded | [clm_A63BD8CCB274](/claim/clm_A63BD8CCB274.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 1,768,000,000 United States dollar | superseded | [clm_AE24472D22A3](/claim/clm_AE24472D22A3.md)
- 2013-12-31 to 2014-03-31 | cash_and_equivalents | 4,494,000,000 United States dollar | superseded | [clm_D3F35C15691E](/claim/clm_D3F35C15691E.md)
- 2013-12-31 to 2014-12-31 | revenue | 16,047,000,000 United States dollar | superseded | [clm_DA3F30725FBC](/claim/clm_DA3F30725FBC.md)
- 2013-12-31 to 2014-12-31 | net_income | 2,856,000,000 United States dollar | superseded | [clm_EAB392B392A6](/claim/clm_EAB392B392A6.md)

## 2014

- 2014-01-24 to 2014-04-25 | shares_outstanding | 1,294,654,966 shares | superseded | [clm_3CB031B85C84](/claim/clm_3CB031B85C84.md)
- 2014-03-31 to 2014-06-30 | total_assets | 40,545,000,000 United States dollar | superseded | [clm_1494484F9640](/claim/clm_1494484F9640.md)
- 2014-03-31 to 2014-06-30 | quarterly_revenue | 4,262,000,000 United States dollar | superseded | [clm_1FD58A7FA766](/claim/clm_1FD58A7FA766.md)
- 2014-03-31 to 2014-06-30 | quarterly_net_income | -2,326,000,000 United States dollar | superseded | [clm_488043ABD908](/claim/clm_488043ABD908.md)
- 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 480,000,000 United States dollar | superseded | [clm_69920E69C585](/claim/clm_69920E69C585.md)
- 2014-03-31 to 2014-06-30 | total_equity | 19,609,000,000 United States dollar | superseded | [clm_6C169755E39F](/claim/clm_6C169755E39F.md)
- 2014-03-31 to 2014-06-30 | cash_and_equivalents | 4,415,000,000 United States dollar | superseded | [clm_7781191E59B7](/claim/clm_7781191E59B7.md)
- 2014-03-31 to 2014-06-30 | quarterly_operating_income | 878,000,000 United States dollar | superseded | [clm_ABF5D1FF086A](/claim/clm_ABF5D1FF086A.md)
- 2014-04-25 to 2014-07-11 | shares_outstanding | 1,267,342,622 shares | superseded | [clm_890C0757F2B4](/claim/clm_890C0757F2B4.md)
- 2014-06-30 to 2014-09-30 | total_equity | 18,970,000,000 United States dollar | superseded | [clm_0C63096BEC06](/claim/clm_0C63096BEC06.md)
- 2014-06-30 to 2014-09-30 | cash_and_equivalents | 3,834,000,000 United States dollar | superseded | [clm_2361A5B388C6](/claim/clm_2361A5B388C6.md)
- 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 500,000,000 United States dollar | superseded | [clm_3A6A9F42C05F](/claim/clm_3A6A9F42C05F.md)
- 2014-06-30 to 2014-09-30 | quarterly_operating_income | 794,000,000 United States dollar | superseded | [clm_5B876A3E604B](/claim/clm_5B876A3E604B.md)
- 2014-06-30 to 2014-09-30 | quarterly_revenue | 4,366,000,000 United States dollar | superseded | [clm_7753D10F263F](/claim/clm_7753D10F263F.md)
- 2014-06-30 to 2014-09-30 | total_assets | 41,640,000,000 United States dollar | superseded | [clm_7785EB61C257](/claim/clm_7785EB61C257.md)
- 2014-06-30 to 2014-09-30 | quarterly_net_income | 676,000,000 United States dollar | superseded | [clm_A732AB1A73B7](/claim/clm_A732AB1A73B7.md)
- 2014-07-11 to 2014-10-10 | shares_outstanding | 1,241,212,669 shares | superseded | [clm_6B91FC340B17](/claim/clm_6B91FC340B17.md)
- 2014-09-30 to 2015-03-31 | quarterly_operating_income | 781,000,000 United States dollar | superseded | [clm_00EEEB0DDA3C](/claim/clm_00EEEB0DDA3C.md)
- 2014-09-30 to 2014-12-31 | total_equity | 19,810,000,000 United States dollar | superseded | [clm_3CF7FFC10E18](/claim/clm_3CF7FFC10E18.md)
- 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 511,000,000 United States dollar | superseded | [clm_4EDFBDDF9BF7](/claim/clm_4EDFBDDF9BF7.md)
- 2014-09-30 to 2014-12-31 | total_assets | 44,476,000,000 United States dollar | superseded | [clm_85B1B11C46D1](/claim/clm_85B1B11C46D1.md)
- 2014-09-30 to 2014-12-31 | cash_and_equivalents | 4,790,000,000 United States dollar | superseded | [clm_88B58696BDC6](/claim/clm_88B58696BDC6.md)
- 2014-09-30 to 2015-03-31 | quarterly_net_income | 673,000,000 United States dollar | superseded | [clm_CBC42BDEB711](/claim/clm_CBC42BDEB711.md)
- 2014-09-30 to 2015-03-31 | quarterly_revenue | 4,353,000,000 United States dollar | superseded | [clm_DEEAEAC22013](/claim/clm_DEEAEAC22013.md)
- 2014-10-10 to 2015-02-02 | shares_outstanding | 1,242,367,268 shares | superseded | [clm_38D602F6C780](/claim/clm_38D602F6C780.md)
- 2014-12-31 to 2015-03-31 | total_equity | 19,906,000,000 United States dollar | superseded | [clm_05C00E1ED2C7](/claim/clm_05C00E1ED2C7.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 2,000,000,000 United States dollar | superseded | [clm_2DFAD9124DBC](/claim/clm_2DFAD9124DBC.md)
- 2014-12-31 to 2026-10-28 | market_cap | 70,600,000,000 United States dollar | superseded | [clm_3C0B62CCF5C5](/claim/clm_3C0B62CCF5C5.md)
- 2014-12-31 to 2015-12-31 | net_income | -865,000,000 United States dollar | superseded | [clm_40FAA375750B](/claim/clm_40FAA375750B.md)
- 2014-12-31 to 2015-03-31 | cash_and_equivalents | 6,328,000,000 United States dollar | superseded | [clm_67CCA639A1A1](/claim/clm_67CCA639A1A1.md)
- 2014-12-31 to 2015-12-31 | revenue | 17,902,000,000 United States dollar | superseded | [clm_7663062AE4F1](/claim/clm_7663062AE4F1.md)
- 2014-12-31 to 2015-12-31 | revenue | 8,790,000,000 United States dollar | superseded | [clm_92C4E291B3B0](/claim/clm_92C4E291B3B0.md)
- 2014-12-31 to 2015-12-31 | net_income | 46,000,000 United States dollar | superseded | [clm_9B232E999B03](/claim/clm_9B232E999B03.md)
- 2014-12-31 to 2015-03-31 | total_assets | 45,132,000,000 United States dollar | superseded | [clm_B08A34D4FA0C](/claim/clm_B08A34D4FA0C.md)
- 2014-12-31 to 2015-12-31 | operating_income | 2,476,000,000 United States dollar | superseded | [clm_DAF0B4354E60](/claim/clm_DAF0B4354E60.md)
- 2014-12-31 to 2015-12-31 | operating_income | 3,514,000,000 United States dollar | superseded | [clm_E380E288F2E0](/claim/clm_E380E288F2E0.md)

## 2015

- 2015-02-02 to 2015-04-20 | shares_outstanding | 1,210,046,829 shares | superseded | [clm_6BA8CEE3E16C](/claim/clm_6BA8CEE3E16C.md)
- 2015-03-31 to 2015-06-30 | quarterly_revenue | 4,448,000,000 United States dollar | superseded | [clm_297C2D685ED2](/claim/clm_297C2D685ED2.md)
- 2015-03-31 to 2015-06-30 | quarterly_operating_income | 732,000,000 United States dollar | superseded | [clm_363005613E28](/claim/clm_363005613E28.md)
- 2015-03-31 to 2015-06-30 | quarterly_net_income | 626,000,000 United States dollar | superseded | [clm_431ED3B70517](/claim/clm_431ED3B70517.md)
- 2015-03-31 to 2015-06-30 | total_assets | 44,841,000,000 United States dollar | superseded | [clm_BCA20C8C96F4](/claim/clm_BCA20C8C96F4.md)
- 2015-03-31 to 2015-06-30 | cash_and_equivalents | 5,473,000,000 United States dollar | superseded | [clm_C18F6C597CBA](/claim/clm_C18F6C597CBA.md)
- 2015-03-31 to 2015-06-30 | total_equity | 19,538,000,000 United States dollar | superseded | [clm_C9925A85F0F7](/claim/clm_C9925A85F0F7.md)
- 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 485,000,000 United States dollar | superseded | [clm_D919480FC160](/claim/clm_D919480FC160.md)
- 2015-04-20 to 2015-07-14 | shares_outstanding | 1,214,821,692 shares | superseded | [clm_03A1B0047C04](/claim/clm_03A1B0047C04.md)
- 2015-06-30 to 2015-09-30 | quarterly_revenue | 4,379,000,000 United States dollar | superseded | [clm_0CD5420FC80E](/claim/clm_0CD5420FC80E.md)
- 2015-06-30 to 2015-09-30 | quarterly_operating_income | 741,000,000 United States dollar | superseded | [clm_24A36446FB0F](/claim/clm_24A36446FB0F.md)
- 2015-06-30 to 2015-09-30 | total_assets | 45,658,000,000 United States dollar | superseded | [clm_A000F83F0EE2](/claim/clm_A000F83F0EE2.md)
- 2015-06-30 to 2015-09-30 | cash_and_equivalents | 4,971,000,000 United States dollar | superseded | [clm_A201228C2CEA](/claim/clm_A201228C2CEA.md)
- 2015-06-30 to 2015-09-30 | quarterly_net_income | 83,000,000 United States dollar | superseded | [clm_E0B8AB84DEA5](/claim/clm_E0B8AB84DEA5.md)
- 2015-06-30 to 2015-09-30 | total_equity | 19,805,000,000 United States dollar | superseded | [clm_E3AEAFAE312C](/claim/clm_E3AEAFAE312C.md)
- 2015-07-01 to 2019-09-01 | ceo | Devin Wenig | superseded | [clm_4ACD54393DE6](/claim/clm_4ACD54393DE6.md)
- 2015-07-14 to 2015-10-26 | shares_outstanding | 1,218,228,091 shares | superseded | [clm_6832483AFCA1](/claim/clm_6832483AFCA1.md)
- 2015-09-30 to 2015-12-31 | total_assets | 18,338,000,000 United States dollar | superseded | [clm_230E376DD726](/claim/clm_230E376DD726.md)
- 2015-09-30 to 2016-03-31 | quarterly_revenue | 2,099,000,000 United States dollar | superseded | [clm_5BAC996B296B](/claim/clm_5BAC996B296B.md)
- 2015-09-30 to 2016-03-31 | quarterly_net_income | 539,000,000 United States dollar | superseded | [clm_6499015CA96C](/claim/clm_6499015CA96C.md)
- 2015-09-30 to 2015-12-31 | total_equity | 6,492,000,000 United States dollar | superseded | [clm_8D33F027852A](/claim/clm_8D33F027852A.md)
- 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 241,000,000 United States dollar | superseded | [clm_8D60B8F52B0D](/claim/clm_8D60B8F52B0D.md)
- 2015-09-30 to 2015-12-31 | cash_and_equivalents | 2,387,000,000 United States dollar | superseded | [clm_A16EF3149AF0](/claim/clm_A16EF3149AF0.md)
- 2015-09-30 to 2016-03-31 | quarterly_operating_income | 578,000,000 United States dollar | superseded | [clm_A5C58D38A869](/claim/clm_A5C58D38A869.md)
- 2015-10-26 to 2016-01-27 | shares_outstanding | 1,200,653,879 shares | superseded | [clm_01DC153E703E](/claim/clm_01DC153E703E.md)
- 2015-12-31 to 2016-03-31 | cash_and_equivalents | 1,832,000,000 United States dollar | superseded | [clm_36A3BB2B9751](/claim/clm_36A3BB2B9751.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 923,000,000 United States dollar | superseded | [clm_46E6947200A0](/claim/clm_46E6947200A0.md)
- 2015-12-31 to 2016-03-31 | total_equity | 6,576,000,000 United States dollar | superseded | [clm_6549CB236855](/claim/clm_6549CB236855.md)
- 2015-12-31 to 2016-12-31 | net_income | 2,947,000,000 United States dollar | superseded | [clm_731B955AC1AD](/claim/clm_731B955AC1AD.md)
- 2015-12-31 to 2016-12-31 | employees | 34,600 | superseded | [clm_891CC8BC3DC8](/claim/clm_891CC8BC3DC8.md)
- 2015-12-31 to 2016-12-31 | net_income | 1,725,000,000 United States dollar | superseded | [clm_8A3E8147AA51](/claim/clm_8A3E8147AA51.md)
- 2015-12-31 to 2016-12-31 | operating_income | 2,197,000,000 United States dollar | superseded | [clm_99E48DD0924E](/claim/clm_99E48DD0924E.md)
- 2015-12-31 to 2016-12-31 | revenue | 8,592,000,000 United States dollar | superseded | [clm_9DCFA0D412E7](/claim/clm_9DCFA0D412E7.md)
- 2015-12-31 to 2016-03-31 | total_assets | 17,785,000,000 United States dollar | superseded | [clm_A153779DA0C8](/claim/clm_A153779DA0C8.md)

## 2016

- 2016-01-27 to 2016-04-22 | shares_outstanding | 1,178,705,177 shares | superseded | [clm_24B646DC7962](/claim/clm_24B646DC7962.md)
- 2016-03-31 to 2016-06-30 | quarterly_revenue | 2,137,000,000 United States dollar | superseded | [clm_0DADACAC26FC](/claim/clm_0DADACAC26FC.md)
- 2016-03-31 to 2016-06-30 | quarterly_operating_income | 614,000,000 United States dollar | superseded | [clm_26CF4B2306F5](/claim/clm_26CF4B2306F5.md)
- 2016-03-31 to 2016-06-30 | total_equity | 6,317,000,000 United States dollar | superseded | [clm_97BCFDED461F](/claim/clm_97BCFDED461F.md)
- 2016-03-31 to 2016-06-30 | cash_and_equivalents | 2,686,000,000 United States dollar | superseded | [clm_B5C984D34F0B](/claim/clm_B5C984D34F0B.md)
- 2016-03-31 to 2016-06-30 | total_assets | 19,608,000,000 United States dollar | superseded | [clm_C59F74C9579D](/claim/clm_C59F74C9579D.md)
- 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 239,000,000 United States dollar | superseded | [clm_F87D67D48324](/claim/clm_F87D67D48324.md)
- 2016-03-31 to 2016-06-30 | quarterly_net_income | 482,000,000 United States dollar | superseded | [clm_FAD3A9598A8C](/claim/clm_FAD3A9598A8C.md)
- 2016-04-22 to 2016-07-19 | shares_outstanding | 1,148,904,240 shares | superseded | [clm_64DE64E2184D](/claim/clm_64DE64E2184D.md)
- 2016-06-30 to 2016-09-30 | cash_and_equivalents | 2,001,000,000 United States dollar | superseded | [clm_093831498D4E](/claim/clm_093831498D4E.md)
- 2016-06-30 to 2016-09-30 | total_assets | 19,993,000,000 United States dollar | superseded | [clm_184F3872580D](/claim/clm_184F3872580D.md)
- 2016-06-30 to 2016-09-30 | quarterly_net_income | 435,000,000 United States dollar | superseded | [clm_267BFEA45888](/claim/clm_267BFEA45888.md)
- 2016-06-30 to 2016-09-30 | total_equity | 6,453,000,000 United States dollar | superseded | [clm_2A3D9CA1CE8C](/claim/clm_2A3D9CA1CE8C.md)
- 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 295,000,000 United States dollar | superseded | [clm_51AC2D0D480A](/claim/clm_51AC2D0D480A.md)
- 2016-06-30 to 2016-09-30 | quarterly_revenue | 2,230,000,000 United States dollar | superseded | [clm_8A9EB3893A2B](/claim/clm_8A9EB3893A2B.md)
- 2016-06-30 to 2016-09-30 | quarterly_operating_income | 531,000,000 United States dollar | superseded | [clm_A6CF6A3CDE5C](/claim/clm_A6CF6A3CDE5C.md)
- 2016-07-19 to 2016-10-18 | shares_outstanding | 1,129,018,848 shares | superseded | [clm_6E4D013808CE](/claim/clm_6E4D013808CE.md)
- 2016-09-30 to 2017-03-31 | quarterly_revenue | 2,217,000,000 United States dollar | superseded | [clm_4A0EA584AC86](/claim/clm_4A0EA584AC86.md)
- 2016-09-30 to 2016-12-31 | total_equity | 6,819,000,000 United States dollar | superseded | [clm_4D6582EF7E16](/claim/clm_4D6582EF7E16.md)
- 2016-09-30 to 2017-03-31 | quarterly_operating_income | 542,000,000 United States dollar | superseded | [clm_7954784BA814](/claim/clm_7954784BA814.md)
- 2016-09-30 to 2016-12-31 | cash_and_equivalents | 1,753,000,000 United States dollar | superseded | [clm_97230CFFC53F](/claim/clm_97230CFFC53F.md)
- 2016-09-30 to 2017-03-31 | quarterly_net_income | 413,000,000 United States dollar | superseded | [clm_ADF5AAF67FA4](/claim/clm_ADF5AAF67FA4.md)
- 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 288,000,000 United States dollar | superseded | [clm_D6F72431A08B](/claim/clm_D6F72431A08B.md)
- 2016-09-30 to 2016-12-31 | total_assets | 20,502,000,000 United States dollar | superseded | [clm_E72A4C738E78](/claim/clm_E72A4C738E78.md)
- 2016-10-18 to 2017-01-30 | shares_outstanding | 1,117,926,440 shares | superseded | [clm_A594DE133593](/claim/clm_A594DE133593.md)
- 2016-12-31 to 2017-03-31 | total_assets | 23,847,000,000 United States dollar | superseded | [clm_05136C574CC7](/claim/clm_05136C574CC7.md)
- 2016-12-31 to 2017-12-31 | net_income | 7,266,000,000 United States dollar | superseded | [clm_19173B19EC5C](/claim/clm_19173B19EC5C.md)
- 2016-12-31 to 2017-12-31 | revenue | 9,298,000,000 United States dollar | superseded | [clm_217E9DBA0177](/claim/clm_217E9DBA0177.md)
- 2016-12-31 to 2017-03-31 | cash_and_equivalents | 1,816,000,000 United States dollar | superseded | [clm_4C3532B41A88](/claim/clm_4C3532B41A88.md)
- 2016-12-31 to 2017-12-31 | operating_income | 2,325,000,000 United States dollar | superseded | [clm_5E3E39CCF0D5](/claim/clm_5E3E39CCF0D5.md)
- 2016-12-31 to 2017-12-31 | revenue | 8,979,000,000 United States dollar | superseded | [clm_745A81C7B26E](/claim/clm_745A81C7B26E.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 1,114,000,000 United States dollar | superseded | [clm_AD69D5850A08](/claim/clm_AD69D5850A08.md)
- 2016-12-31 to 2017-03-31 | total_equity | 10,539,000,000 United States dollar | superseded | [clm_E25A54486C4A](/claim/clm_E25A54486C4A.md)
- 2016-12-31 to 2025-12-31 | employees | 12,600 | superseded | [clm_EFFEDC98388B](/claim/clm_EFFEDC98388B.md)

## 2017

- 2017-01-30 to 2017-04-17 | shares_outstanding | 1,087,042,601 shares | superseded | [clm_9F8BC26E9632](/claim/clm_9F8BC26E9632.md)
- 2017-03-20 | owned_by | Pierre Omidyar | valid | [clm_62AC602ACC70](/claim/clm_62AC602ACC70.md)
- 2017-03-20 | owned_by | BlackRock | unverified | [clm_71CF26EB085C](/claim/clm_71CF26EB085C.md)
- 2017-03-20 | owned_by | The Vanguard Group | unverified | [clm_9CB0DE8A8B65](/claim/clm_9CB0DE8A8B65.md)
- 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 278,000,000 United States dollar | superseded | [clm_034EAAE7D3C8](/claim/clm_034EAAE7D3C8.md)
- 2017-03-31 to 2017-06-30 | quarterly_net_income | 1,035,000,000 United States dollar | superseded | [clm_241E9C5EDFE5](/claim/clm_241E9C5EDFE5.md)
- 2017-03-31 to 2017-06-30 | cash_and_equivalents | 1,979,000,000 United States dollar | superseded | [clm_3D8357424787](/claim/clm_3D8357424787.md)
- 2017-03-31 to 2017-06-30 | total_assets | 24,808,000,000 United States dollar | superseded | [clm_82D78BCA1E41](/claim/clm_82D78BCA1E41.md)
- 2017-03-31 to 2017-06-30 | total_equity | 11,595,000,000 United States dollar | superseded | [clm_F1BB74C30F46](/claim/clm_F1BB74C30F46.md)
- 2017-03-31 to 2017-06-30 | quarterly_operating_income | 546,000,000 United States dollar | superseded | [clm_FD073187FB9D](/claim/clm_FD073187FB9D.md)
- 2017-04-17 to 2017-07-17 | shares_outstanding | 1,082,338,026 shares | superseded | [clm_2DAC7EF8156F](/claim/clm_2DAC7EF8156F.md)
- 2017-06-30 to 2017-09-30 | quarterly_net_income | 27,000,000 United States dollar | superseded | [clm_016F86B279DF](/claim/clm_016F86B279DF.md)
- 2017-06-30 to 2017-09-30 | total_equity | 11,474,000,000 United States dollar | superseded | [clm_0EF489725BBB](/claim/clm_0EF489725BBB.md)
- 2017-06-30 to 2017-09-30 | cash_and_equivalents | 2,636,000,000 United States dollar | superseded | [clm_36F9E0AC975A](/claim/clm_36F9E0AC975A.md)
- 2017-06-30 to 2017-09-30 | quarterly_revenue | 2,328,000,000 United States dollar | superseded | [clm_3D53BCF75E16](/claim/clm_3D53BCF75E16.md)
- 2017-06-30 to 2017-09-30 | quarterly_operating_income | 478,000,000 United States dollar | superseded | [clm_512D24024D24](/claim/clm_512D24024D24.md)
- 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 313,000,000 United States dollar | superseded | [clm_65D0A83931EF](/claim/clm_65D0A83931EF.md)
- 2017-06-30 to 2017-09-30 | total_assets | 27,483,000,000 United States dollar | superseded | [clm_996648402AB3](/claim/clm_996648402AB3.md)
- 2017-07-17 to 2017-10-16 | shares_outstanding | 1,070,315,519 shares | superseded | [clm_F71713AB7AEB](/claim/clm_F71713AB7AEB.md)
- 2017-09-30 to 2018-03-31 | quarterly_revenue | 2,498,000,000 United States dollar | superseded | [clm_07952479AA39](/claim/clm_07952479AA39.md)
- 2017-09-30 to 2017-12-31 | total_equity | 11,283,000,000 United States dollar | superseded | [clm_1705DDD16F15](/claim/clm_1705DDD16F15.md)
- 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 316,000,000 United States dollar | superseded | [clm_420C14C1E554](/claim/clm_420C14C1E554.md)
- 2017-09-30 to 2018-03-31 | quarterly_net_income | 523,000,000 United States dollar | superseded | [clm_8DF44F935138](/claim/clm_8DF44F935138.md)
- 2017-09-30 to 2017-12-31 | total_assets | 25,943,000,000 United States dollar | superseded | [clm_DB6D336F102C](/claim/clm_DB6D336F102C.md)
- 2017-09-30 to 2017-12-31 | cash_and_equivalents | 1,760,000,000 United States dollar | superseded | [clm_F7A48B128643](/claim/clm_F7A48B128643.md)
- 2017-10-16 to 2018-01-29 | shares_outstanding | 1,044,571,141 shares | superseded | [clm_CB2948FE8B58](/claim/clm_CB2948FE8B58.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 1,224,000,000 United States dollar | superseded | [clm_0C02E8A6DE37](/claim/clm_0C02E8A6DE37.md)
- 2017-12-31 to 2018-12-31 | net_income | -1,016,000,000 United States dollar | superseded | [clm_12271651B0E1](/claim/clm_12271651B0E1.md)
- 2017-12-31 to 2018-03-31 | cash_and_equivalents | 2,120,000,000 United States dollar | superseded | [clm_2687A0D06149](/claim/clm_2687A0D06149.md)
- 2017-12-31 to 2018-12-31 | operating_income | 2,265,000,000 United States dollar | superseded | [clm_2AB841C49B24](/claim/clm_2AB841C49B24.md)
- 2017-12-31 to 2018-12-31 | revenue | 9,927,000,000 United States dollar | superseded | [clm_62F5158BC7CD](/claim/clm_62F5158BC7CD.md)
- 2017-12-31 to 2018-03-31 | total_equity | 8,063,000,000 United States dollar | superseded | [clm_653897F6CF97](/claim/clm_653897F6CF97.md)
- 2017-12-31 to 2018-03-31 | total_assets | 25,981,000,000 United States dollar | superseded | [clm_748477622E10](/claim/clm_748477622E10.md)

## 2018

- 2018-01-29 to 2018-04-23 | shares_outstanding | 1,012,079,673 shares | superseded | [clm_3EE8887A8B07](/claim/clm_3EE8887A8B07.md)
- 2018-03-31 to 2018-06-30 | quarterly_revenue | 2,580,000,000 United States dollar | superseded | [clm_0F02276183F3](/claim/clm_0F02276183F3.md)
- 2018-03-31 to 2018-06-30 | quarterly_operating_income | 579,000,000 United States dollar | superseded | [clm_16F6F301759D](/claim/clm_16F6F301759D.md)
- 2018-03-31 to 2018-06-30 | quarterly_net_income | 407,000,000 United States dollar | superseded | [clm_310CBDD9EFD3](/claim/clm_310CBDD9EFD3.md)
- 2018-03-31 to 2018-06-30 | total_equity | 7,596,000,000 United States dollar | superseded | [clm_3CD1CBBDB2CF](/claim/clm_3CD1CBBDB2CF.md)
- 2018-03-31 to 2018-06-30 | total_assets | 24,555,000,000 United States dollar | superseded | [clm_8E2B1C465D93](/claim/clm_8E2B1C465D93.md)
- 2018-03-31 to 2018-06-30 | cash_and_equivalents | 2,527,000,000 United States dollar | superseded | [clm_CE656DB6D2F7](/claim/clm_CE656DB6D2F7.md)
- 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 334,000,000 United States dollar | superseded | [clm_D491C9177F9D](/claim/clm_D491C9177F9D.md)
- 2018-04-23 to 2018-07-16 | shares_outstanding | 993,978,034 shares | superseded | [clm_E834A47E960A](/claim/clm_E834A47E960A.md)
- 2018-06-30 to 2018-09-30 | quarterly_revenue | 2,640,000,000 United States dollar | superseded | [clm_323D8E7F4039](/claim/clm_323D8E7F4039.md)
- 2018-06-30 to 2018-09-30 | quarterly_net_income | 642,000,000 United States dollar | superseded | [clm_5C44E7A79808](/claim/clm_5C44E7A79808.md)
- 2018-06-30 to 2018-09-30 | total_equity | 7,146,000,000 United States dollar | superseded | [clm_A522A24C9DC6](/claim/clm_A522A24C9DC6.md)
- 2018-06-30 to 2018-09-30 | total_assets | 23,988,000,000 United States dollar | superseded | [clm_C2D7CAE3FE7D](/claim/clm_C2D7CAE3FE7D.md)
- 2018-06-30 to 2018-09-30 | quarterly_operating_income | 406,000,000 United States dollar | superseded | [clm_CC5DA3249869](/claim/clm_CC5DA3249869.md)
- 2018-06-30 to 2018-09-30 | cash_and_equivalents | 1,619,000,000 United States dollar | superseded | [clm_DC406133FEB1](/claim/clm_DC406133FEB1.md)
- 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 352,000,000 United States dollar | superseded | [clm_F3BE9B1CD7E0](/claim/clm_F3BE9B1CD7E0.md)
- 2018-07-16 to 2018-10-29 | shares_outstanding | 989,549,611 shares | superseded | [clm_0A1E745D12F0](/claim/clm_0A1E745D12F0.md)
- 2018-09-30 to 2019-03-31 | quarterly_revenue | 2,649,000,000 United States dollar | superseded | [clm_2023D76ED259](/claim/clm_2023D76ED259.md)
- 2018-09-30 to 2018-12-31 | total_assets | 23,652,000,000 United States dollar | superseded | [clm_562AEECAC76D](/claim/clm_562AEECAC76D.md)
- 2018-09-30 to 2018-12-31 | total_equity | 6,929,000,000 United States dollar | superseded | [clm_9A26F4F052AF](/claim/clm_9A26F4F052AF.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | 556,000,000 United States dollar | superseded | [clm_A09CEF32916D](/claim/clm_A09CEF32916D.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 307,000,000 United States dollar | superseded | [clm_D8A66E32E2DC](/claim/clm_D8A66E32E2DC.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 2,086,000,000 United States dollar | superseded | [clm_ED7DFFDA448C](/claim/clm_ED7DFFDA448C.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | 721,000,000 United States dollar | superseded | [clm_FC71156159AC](/claim/clm_FC71156159AC.md)
- 2018-10-29 to 2019-01-25 | shares_outstanding | 962,827,199 shares | superseded | [clm_564765895E0F](/claim/clm_564765895E0F.md)
- 2018-12-31 to 2019-12-31 | revenue | 10,746,000,000 United States dollar | superseded | [clm_194CA894D72D](/claim/clm_194CA894D72D.md)
- 2018-12-31 to 2019-03-31 | total_assets | 22,819,000,000 United States dollar | superseded | [clm_29408A0CF763](/claim/clm_29408A0CF763.md)
- 2018-12-31 to 2019-12-31 | operating_income | 2,222,000,000 United States dollar | superseded | [clm_34E303060BF4](/claim/clm_34E303060BF4.md)
- 2018-12-31 to 2019-12-31 | net_income | 2,530,000,000 United States dollar | superseded | [clm_90916CB0C028](/claim/clm_90916CB0C028.md)
- 2018-12-31 to 2019-12-31 | operating_income | 1,752,000,000 United States dollar | superseded | [clm_9F298EF95DC8](/claim/clm_9F298EF95DC8.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 1,285,000,000 United States dollar | superseded | [clm_A43ABAC20307](/claim/clm_A43ABAC20307.md)
- 2018-12-31 to 2019-12-31 | revenue | 8,650,000,000 United States dollar | superseded | [clm_CC1E715ED091](/claim/clm_CC1E715ED091.md)
- 2018-12-31 to 2019-03-31 | total_equity | 6,281,000,000 United States dollar | superseded | [clm_DBF7845D890A](/claim/clm_DBF7845D890A.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 2,202,000,000 United States dollar | superseded | [clm_E1B8C1C5F769](/claim/clm_E1B8C1C5F769.md)

## 2019

- 2019-01-25 to 2019-04-22 | shares_outstanding | 914,880,451 shares | superseded | [clm_0229AEBFE57A](/claim/clm_0229AEBFE57A.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 1,695,000,000 United States dollar | superseded | [clm_33589C64DD0B](/claim/clm_33589C64DD0B.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | 518,000,000 United States dollar | superseded | [clm_42F585700421](/claim/clm_42F585700421.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | 609,000,000 United States dollar | superseded | [clm_50A5577B6B09](/claim/clm_50A5577B6B09.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 297,000,000 United States dollar | superseded | [clm_9232C6F2F2FD](/claim/clm_9232C6F2F2FD.md)
- 2019-03-31 to 2019-06-30 | quarterly_revenue | 2,643,000,000 United States dollar | superseded | [clm_9E59DB80F0CB](/claim/clm_9E59DB80F0CB.md)
- 2019-03-31 to 2019-06-30 | total_equity | 5,203,000,000 United States dollar | superseded | [clm_DBF8CB2A98F1](/claim/clm_DBF8CB2A98F1.md)
- 2019-03-31 to 2019-06-30 | total_assets | 22,329,000,000 United States dollar | superseded | [clm_FCF41EB6E252](/claim/clm_FCF41EB6E252.md)
- 2019-04-22 to 2019-07-15 | shares_outstanding | 871,527,401 shares | superseded | [clm_FC0EE9D92FF0](/claim/clm_FC0EE9D92FF0.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 1,508,000,000 United States dollar | superseded | [clm_0D935692B24C](/claim/clm_0D935692B24C.md)
- 2019-06-30 to 2019-09-30 | quarterly_revenue | 2,687,000,000 United States dollar | superseded | [clm_3152DDB9F1DB](/claim/clm_3152DDB9F1DB.md)
- 2019-06-30 to 2019-09-30 | total_equity | 4,106,000,000 United States dollar | superseded | [clm_350E89BF58EE](/claim/clm_350E89BF58EE.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | 402,000,000 United States dollar | superseded | [clm_53B0A3F93F5C](/claim/clm_53B0A3F93F5C.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | 561,000,000 United States dollar | superseded | [clm_9521C623CB40](/claim/clm_9521C623CB40.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 322,000,000 United States dollar | superseded | [clm_E90126CD51AC](/claim/clm_E90126CD51AC.md)
- 2019-06-30 to 2019-09-30 | total_assets | 21,169,000,000 United States dollar | superseded | [clm_EA677DB2EAB3](/claim/clm_EA677DB2EAB3.md)
- 2019-07-15 to 2019-10-21 | shares_outstanding | 838,763,599 shares | superseded | [clm_51E7F94F8424](/claim/clm_51E7F94F8424.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | 310,000,000 United States dollar | superseded | [clm_119C767F1663](/claim/clm_119C767F1663.md)
- 2019-09-30 to 2019-12-31 | total_equity | 3,270,000,000 United States dollar | superseded | [clm_37A1B9AF30B4](/claim/clm_37A1B9AF30B4.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 897,000,000 United States dollar | superseded | [clm_5CAA70DBDC3C](/claim/clm_5CAA70DBDC3C.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | 532,000,000 United States dollar | superseded | [clm_7035BE6E575F](/claim/clm_7035BE6E575F.md)
- 2019-09-30 to 2019-12-31 | total_assets | 18,714,000,000 United States dollar | superseded | [clm_8A9F8EC8E59A](/claim/clm_8A9F8EC8E59A.md)
- 2019-10-21 to 2020-01-27 | shares_outstanding | 813,525,054 shares | superseded | [clm_495E652946F8](/claim/clm_495E652946F8.md)
- 2019-12-31 to 2020-12-31 | revenue | 10,800,000,000 United States dollar | superseded | [clm_0A14D8AE1E85](/claim/clm_0A14D8AE1E85.md)
- 2019-12-31 to 2020-03-31 | total_assets | 18,174,000,000 United States dollar | superseded | [clm_249FD7B13A9B](/claim/clm_249FD7B13A9B.md)
- 2019-12-31 to 2020-12-31 | net_income | 1,786,000,000 United States dollar | superseded | [clm_29B6331B4AE3](/claim/clm_29B6331B4AE3.md)
- 2019-12-31 to 2020-03-31 | total_equity | 2,870,000,000 United States dollar | superseded | [clm_6FB4FBD75C22](/claim/clm_6FB4FBD75C22.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 1,240,000,000 United States dollar | superseded | [clm_76350D860E21](/claim/clm_76350D860E21.md)
- 2019-12-31 to 2020-12-31 | operating_income | 1,770,000,000 United States dollar | superseded | [clm_A08A20D6D43A](/claim/clm_A08A20D6D43A.md)
- 2019-12-31 to 2020-12-31 | operating_income | 2,321,000,000 United States dollar | superseded | [clm_A921106222CB](/claim/clm_A921106222CB.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 975,000,000 United States dollar | superseded | [clm_AEBF0AB9EDF1](/claim/clm_AEBF0AB9EDF1.md)
- 2019-12-31 to 2020-12-31 | revenue | 7,429,000,000 United States dollar | superseded | [clm_B1EED7059C8F](/claim/clm_B1EED7059C8F.md)

## 2020

- 2020-01-27 to 2020-04-15 | shares_outstanding | 796,080,826 shares | superseded | [clm_2CA1C567F980](/claim/clm_2CA1C567F980.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | 629,000,000 United States dollar | superseded | [clm_0EF692477671](/claim/clm_0EF692477671.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | 3,412,000,000 United States dollar | superseded | [clm_2A3521FE08A5](/claim/clm_2A3521FE08A5.md)
- 2020-03-31 to 2020-06-30 | total_assets | 18,929,000,000 United States dollar | superseded | [clm_3296670ECDC6](/claim/clm_3296670ECDC6.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 2,374,000,000 United States dollar | superseded | [clm_9A6F2AAAB600](/claim/clm_9A6F2AAAB600.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 880,000,000 United States dollar | superseded | [clm_C539AA191D55](/claim/clm_C539AA191D55.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 267,000,000 United States dollar | superseded | [clm_C923B796D586](/claim/clm_C923B796D586.md)
- 2020-03-31 to 2020-06-30 | total_equity | 2,115,000,000 United States dollar | superseded | [clm_D9DC88FFB7EE](/claim/clm_D9DC88FFB7EE.md)
- 2020-04-15 to 2020-04-27 | shares_outstanding | 700,853,307 shares | superseded | [clm_FC53A9A0A9DC](/claim/clm_FC53A9A0A9DC.md)
- 2020-04-27 to 2020-07-27 | shares_outstanding | 700,853,258 shares | superseded | [clm_39D0DB05D2EC](/claim/clm_39D0DB05D2EC.md)
- 2020-04-27 | ceo | Jamie Iannone | valid | [clm_BA83B97745FD](/claim/clm_BA83B97745FD.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | 746,000,000 United States dollar | superseded | [clm_2C24109ED075](/claim/clm_2C24109ED075.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | 821,000,000 United States dollar | superseded | [clm_5332BEDC32BA](/claim/clm_5332BEDC32BA.md)
- 2020-06-30 to 2020-09-30 | total_assets | 20,014,000,000 United States dollar | superseded | [clm_59BAAA855305](/claim/clm_59BAAA855305.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 1,006,000,000 United States dollar | superseded | [clm_5DEBE349F0E2](/claim/clm_5DEBE349F0E2.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 2,865,000,000 United States dollar | superseded | [clm_9BABD2AF1DE0](/claim/clm_9BABD2AF1DE0.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 308,000,000 United States dollar | superseded | [clm_C70060482527](/claim/clm_C70060482527.md)
- 2020-06-30 to 2020-09-30 | total_equity | 2,902,000,000 United States dollar | superseded | [clm_CDDF62163F37](/claim/clm_CDDF62163F37.md)
- 2020-07-27 to 2020-10-26 | shares_outstanding | 699,881,116 shares | superseded | [clm_B84901E115E5](/claim/clm_B84901E115E5.md)
- 2020-09-30 to 2020-12-31 | total_assets | 18,421,000,000 United States dollar | superseded | [clm_1CB210939F5A](/claim/clm_1CB210939F5A.md)
- 2020-09-30 to 2020-12-31 | total_equity | 2,920,000,000 United States dollar | superseded | [clm_314BE1CBF1C8](/claim/clm_314BE1CBF1C8.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 963,000,000 United States dollar | superseded | [clm_329C9D6A961D](/claim/clm_329C9D6A961D.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | 664,000,000 United States dollar | superseded | [clm_3613E1EA2E0C](/claim/clm_3613E1EA2E0C.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | 679,000,000 United States dollar | superseded | [clm_3E2FA5997815](/claim/clm_3E2FA5997815.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 2,606,000,000 United States dollar | superseded | [clm_43357A5CB20A](/claim/clm_43357A5CB20A.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 287,000,000 United States dollar | superseded | [clm_4E08FD00D38C](/claim/clm_4E08FD00D38C.md)
- 2020-10-26 to 2021-02-01 | shares_outstanding | 689,338,530 shares | superseded | [clm_B919CD9925DF](/claim/clm_B919CD9925DF.md)
- 2020-12-31 to 2021-03-31 | total_equity | 3,561,000,000 United States dollar | superseded | [clm_1FBBDC39A115](/claim/clm_1FBBDC39A115.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 1,087,000,000 United States dollar | superseded | [clm_3DCE1EA45334](/claim/clm_3DCE1EA45334.md)
- 2020-12-31 to 2021-12-31 | operating_income | 2,711,000,000 United States dollar | superseded | [clm_6C208AF43452](/claim/clm_6C208AF43452.md)
- 2020-12-31 to 2021-12-31 | revenue | 10,271,000,000 United States dollar | superseded | [clm_6C3C7B45B226](/claim/clm_6C3C7B45B226.md)
- 2020-12-31 to 2021-03-31 | total_assets | 19,310,000,000 United States dollar | superseded | [clm_8D43DB1308A1](/claim/clm_8D43DB1308A1.md)
- 2020-12-31 to 2021-12-31 | revenue | 8,894,000,000 United States dollar | superseded | [clm_9431EF66BCDF](/claim/clm_9431EF66BCDF.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 1,428,000,000 United States dollar | superseded | [clm_B86FBCBF594D](/claim/clm_B86FBCBF594D.md)
- 2020-12-31 to 2021-12-31 | operating_income | 2,636,000,000 United States dollar | superseded | [clm_DCD6A06D1CA4](/claim/clm_DCD6A06D1CA4.md)
- 2020-12-31 to 2021-12-31 | net_income | 5,667,000,000 United States dollar | superseded | [clm_EAA696819DA2](/claim/clm_EAA696819DA2.md)

## 2021

- 2021-02-01 to 2021-04-26 | shares_outstanding | 680,445,767 shares | superseded | [clm_EEFC1E12DF8D](/claim/clm_EEFC1E12DF8D.md)
- 2021-03-31 to 2021-06-30 | total_equity | 3,770,000,000 United States dollar | superseded | [clm_1B08F66935AC](/claim/clm_1B08F66935AC.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | 842,000,000 United States dollar | superseded | [clm_1F779A554389](/claim/clm_1F779A554389.md)
- 2021-03-31 to 2021-06-30 | total_assets | 18,731,000,000 United States dollar | superseded | [clm_81DB07336F90](/claim/clm_81DB07336F90.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 318,000,000 United States dollar | superseded | [clm_8C10BD3BFAEF](/claim/clm_8C10BD3BFAEF.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 3,023,000,000 United States dollar | superseded | [clm_B2B531326DD8](/claim/clm_B2B531326DD8.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 1,667,000,000 United States dollar | superseded | [clm_D043F86E80FF](/claim/clm_D043F86E80FF.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | 641,000,000 United States dollar | superseded | [clm_D3CE4FE3F5FA](/claim/clm_D3CE4FE3F5FA.md)
- 2021-04-26 to 2021-08-09 | shares_outstanding | 681,261,636 shares | superseded | [clm_5608C88CD7F2](/claim/clm_5608C88CD7F2.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 2,128,000,000 United States dollar | superseded | [clm_14B74516E92F](/claim/clm_14B74516E92F.md)
- 2021-06-30 to 2021-09-30 | total_equity | 13,016,000,000 United States dollar | superseded | [clm_171B0EE37CEE](/claim/clm_171B0EE37CEE.md)
- 2021-06-30 to 2021-09-30 | total_assets | 31,823,000,000 United States dollar | superseded | [clm_1C11AB62E11D](/claim/clm_1C11AB62E11D.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 2,668,000,000 United States dollar | superseded | [clm_58A2B91F71A7](/claim/clm_58A2B91F71A7.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | 10,734,000,000 United States dollar | superseded | [clm_9DE2156B97FA](/claim/clm_9DE2156B97FA.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 350,000,000 United States dollar | superseded | [clm_CA1634F8A38F](/claim/clm_CA1634F8A38F.md)
- 2021-08-09 to 2021-10-25 | shares_outstanding | 650,055,805 shares | superseded | [clm_8BDAB79474CC](/claim/clm_8BDAB79474CC.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | 662,000,000 United States dollar | superseded | [clm_0C5DB867E9A7](/claim/clm_0C5DB867E9A7.md)
- 2021-09-30 to 2021-12-31 | total_assets | 29,257,000,000 United States dollar | superseded | [clm_31AE054B485B](/claim/clm_31AE054B485B.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 2,501,000,000 United States dollar | superseded | [clm_4683DE808FEF](/claim/clm_4683DE808FEF.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 1,244,000,000 United States dollar | superseded | [clm_7484F8749026](/claim/clm_7484F8749026.md)
- 2021-09-30 to 2021-12-31 | total_equity | 10,945,000,000 United States dollar | superseded | [clm_ABE7841149F8](/claim/clm_ABE7841149F8.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | 264,000,000 United States dollar | superseded | [clm_E2593CF7A5CB](/claim/clm_E2593CF7A5CB.md)
- 2021-10-25 to 2022-02-21 | shares_outstanding | 626,003,781 shares | superseded | [clm_1965F6B10DBC](/claim/clm_1965F6B10DBC.md)
- 2021-12-31 to 2022-03-31 | total_equity | 9,778,000,000 United States dollar | superseded | [clm_20601D21A9A4](/claim/clm_20601D21A9A4.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 1,379,000,000 United States dollar | superseded | [clm_4B77859A1414](/claim/clm_4B77859A1414.md)
- 2021-12-31 to 2022-03-31 | total_assets | 26,626,000,000 United States dollar | superseded | [clm_4EC49B6DAF7D](/claim/clm_4EC49B6DAF7D.md)
- 2021-12-31 to 2022-12-31 | revenue | 10,420,000,000 United States dollar | superseded | [clm_6E6ACCEF5000](/claim/clm_6E6ACCEF5000.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 1,325,000,000 United States dollar | superseded | [clm_B706D621A238](/claim/clm_B706D621A238.md)
- 2021-12-31 to 2022-12-31 | net_income | 13,608,000,000 United States dollar | superseded | [clm_D750FD1CC198](/claim/clm_D750FD1CC198.md)
- 2021-12-31 to 2022-12-31 | operating_income | 2,923,000,000 United States dollar | superseded | [clm_E93C84F5767A](/claim/clm_E93C84F5767A.md)

## 2022

- 2022-02-21 to 2022-05-02 | shares_outstanding | 587,528,915 shares | superseded | [clm_C4477E095D77](/claim/clm_C4477E095D77.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | 692,000,000 United States dollar | superseded | [clm_38B4B7941800](/claim/clm_38B4B7941800.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 2,483,000,000 United States dollar | superseded | [clm_3B0D2BC46B42](/claim/clm_3B0D2BC46B42.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 1,798,000,000 United States dollar | superseded | [clm_42C4112E3E80](/claim/clm_42C4112E3E80.md)
- 2022-03-31 to 2022-06-30 | total_assets | 22,980,000,000 United States dollar | superseded | [clm_691ADF8922B7](/claim/clm_691ADF8922B7.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | -1,341,000,000 United States dollar | superseded | [clm_723AA6BB067F](/claim/clm_723AA6BB067F.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 301,000,000 United States dollar | superseded | [clm_BD4CC6B7E677](/claim/clm_BD4CC6B7E677.md)
- 2022-03-31 to 2022-06-30 | total_equity | 7,054,000,000 United States dollar | superseded | [clm_F124EE3853E0](/claim/clm_F124EE3853E0.md)
- 2022-05-02 to 2022-08-01 | shares_outstanding | 559,842,135 shares | superseded | [clm_AA5EE95BFB52](/claim/clm_AA5EE95BFB52.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 2,422,000,000 United States dollar | superseded | [clm_13455BCE99DF](/claim/clm_13455BCE99DF.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | 525,000,000 United States dollar | superseded | [clm_1AC106CB50E7](/claim/clm_1AC106CB50E7.md)
- 2022-06-30 to 2022-09-30 | total_equity | 5,243,000,000 United States dollar | superseded | [clm_33BDBB1A9A5F](/claim/clm_33BDBB1A9A5F.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | -531,000,000 United States dollar | superseded | [clm_7C9FF350BB32](/claim/clm_7C9FF350BB32.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 344,000,000 United States dollar | superseded | [clm_842EC23A2312](/claim/clm_842EC23A2312.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 1,742,000,000 United States dollar | superseded | [clm_CEBD7EF9B3AC](/claim/clm_CEBD7EF9B3AC.md)
- 2022-06-30 to 2022-09-30 | total_assets | 19,653,000,000 United States dollar | superseded | [clm_F8518B9E92AF](/claim/clm_F8518B9E92AF.md)
- 2022-08-01 to 2022-11-01 | shares_outstanding | 549,367,835 shares | superseded | [clm_2165D452D007](/claim/clm_2165D452D007.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 345,000,000 United States dollar | superseded | [clm_348A59465C07](/claim/clm_348A59465C07.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 2,380,000,000 United States dollar | superseded | [clm_3ACF73DC44C8](/claim/clm_3ACF73DC44C8.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 2,037,000,000 United States dollar | superseded | [clm_4DF0A89C7342](/claim/clm_4DF0A89C7342.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | -69,000,000 United States dollar | superseded | [clm_7C460666C1EF](/claim/clm_7C460666C1EF.md)
- 2022-09-30 to 2022-12-31 | total_equity | 4,853,000,000 United States dollar | superseded | [clm_9468A375FFE8](/claim/clm_9468A375FFE8.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | 568,000,000 United States dollar | superseded | [clm_D82B3EA6CE3E](/claim/clm_D82B3EA6CE3E.md)
- 2022-09-30 to 2022-12-31 | total_assets | 19,097,000,000 United States dollar | superseded | [clm_FA159F420ACF](/claim/clm_FA159F420ACF.md)
- 2022-11-01 to 2023-02-21 | shares_outstanding | 542,659,087 shares | superseded | [clm_73F84C40FDCF](/claim/clm_73F84C40FDCF.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 2,154,000,000 United States dollar | superseded | [clm_0E674A0A9171](/claim/clm_0E674A0A9171.md)
- 2022-12-31 to 2023-03-31 | total_equity | 5,153,000,000 United States dollar | superseded | [clm_147C575CC3C7](/claim/clm_147C575CC3C7.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 1,330,000,000 United States dollar | superseded | [clm_3A618903696F](/claim/clm_3A618903696F.md)
- 2022-12-31 to 2023-03-31 | total_assets | 20,850,000,000 United States dollar | superseded | [clm_4B3F9B08C31C](/claim/clm_4B3F9B08C31C.md)
- 2022-12-31 to 2023-12-31 | net_income | -1,269,000,000 United States dollar | superseded | [clm_60D66F5525AE](/claim/clm_60D66F5525AE.md)
- 2022-12-31 to 2023-12-31 | revenue | 9,795,000,000 United States dollar | superseded | [clm_B2DCCE8F600E](/claim/clm_B2DCCE8F600E.md)
- 2022-12-31 to 2023-12-31 | operating_income | 2,350,000,000 United States dollar | superseded | [clm_F1F8E1CEF213](/claim/clm_F1F8E1CEF213.md)

## 2023

- 2023-02-21 to 2023-04-24 | shares_outstanding | 536,880,282 shares | superseded | [clm_991CCAEB6B4C](/claim/clm_991CCAEB6B4C.md)
- 2023-03-14 | board_member | Shripriya Mahesh | valid | [clm_05976D7FD178](/claim/clm_05976D7FD178.md)
- 2023-03-31 to 2023-06-30 | total_equity | 5,387,000,000 United States dollar | superseded | [clm_4841354FAC8E](/claim/clm_4841354FAC8E.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 2,082,000,000 United States dollar | superseded | [clm_4847196C95FD](/claim/clm_4847196C95FD.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | 558,000,000 United States dollar | superseded | [clm_ADB70B9899CD](/claim/clm_ADB70B9899CD.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 2,510,000,000 United States dollar | superseded | [clm_BB809266DB44](/claim/clm_BB809266DB44.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | 567,000,000 United States dollar | superseded | [clm_BC9F3C9BA9D8](/claim/clm_BC9F3C9BA9D8.md)
- 2023-03-31 to 2023-06-30 | total_assets | 20,004,000,000 United States dollar | superseded | [clm_BE7132D2C597](/claim/clm_BE7132D2C597.md)
- 2023-04-24 to 2023-05-09 | shares_outstanding | 534,503,131 shares | superseded | [clm_ADA6CD5DB7AC](/claim/clm_ADA6CD5DB7AC.md)
- 2023-05-09 to 2023-07-24 | shares_outstanding | 534,736,900 shares | superseded | [clm_A4444A38C3B5](/claim/clm_A4444A38C3B5.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | 518,000,000 United States dollar | superseded | [clm_2636B4E33204](/claim/clm_2636B4E33204.md)
- 2023-06-30 to 2023-09-30 | total_assets | 19,956,000,000 United States dollar | superseded | [clm_32E478FD1C10](/claim/clm_32E478FD1C10.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 2,268,000,000 United States dollar | superseded | [clm_41125B4B4C4C](/claim/clm_41125B4B4C4C.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 171,000,000 United States dollar | superseded | [clm_4E6BA62013D3](/claim/clm_4E6BA62013D3.md)
- 2023-06-30 to 2023-09-30 | total_equity | 5,268,000,000 United States dollar | superseded | [clm_759505892E5B](/claim/clm_759505892E5B.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 2,540,000,000 United States dollar | superseded | [clm_F1ECA3A98A04](/claim/clm_F1ECA3A98A04.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 392,000,000 United States dollar | superseded | [clm_FFDD9A30B463](/claim/clm_FFDD9A30B463.md)
- 2023-07-24 to 2023-11-03 | shares_outstanding | 532,157,390 shares | superseded | [clm_3D562FA4309D](/claim/clm_3D562FA4309D.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | 455,000,000 United States dollar | superseded | [clm_38AC96E13ED0](/claim/clm_38AC96E13ED0.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 2,500,000,000 United States dollar | superseded | [clm_420039679D65](/claim/clm_420039679D65.md)
- 2023-09-30 to 2023-12-31 | total_equity | 5,899,000,000 United States dollar | superseded | [clm_5A26DB81C4C3](/claim/clm_5A26DB81C4C3.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 2,550,000,000 United States dollar | superseded | [clm_A5FCAAA797FF](/claim/clm_A5FCAAA797FF.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 401,000,000 United States dollar | superseded | [clm_A776389338A3](/claim/clm_A776389338A3.md)
- 2023-09-30 to 2023-12-31 | total_assets | 21,184,000,000 United States dollar | superseded | [clm_C83AF8FD24FE](/claim/clm_C83AF8FD24FE.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | 1,305,000,000 United States dollar | superseded | [clm_E9A1468BC369](/claim/clm_E9A1468BC369.md)
- 2023-11-03 to 2024-02-23 | shares_outstanding | 519,000,000 shares | superseded | [clm_8B4FFDE381DE](/claim/clm_8B4FFDE381DE.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 1,544,000,000 United States dollar | superseded | [clm_2C5FD3EB987F](/claim/clm_2C5FD3EB987F.md)
- 2023-12-31 to 2024-03-31 | total_equity | 6,396,000,000 United States dollar | superseded | [clm_53D3F206910C](/claim/clm_53D3F206910C.md)
- 2023-12-31 to 2024-12-31 | net_income | 2,767,000,000 United States dollar | superseded | [clm_54466FA06A71](/claim/clm_54466FA06A71.md)
- 2023-12-31 to 2024-12-31 | operating_income | 1,941,000,000 United States dollar | superseded | [clm_5CD327EAA74D](/claim/clm_5CD327EAA74D.md)
- 2023-12-31 to 2024-12-31 | revenue | 10,112,000,000 United States dollar | superseded | [clm_5D1993C897E5](/claim/clm_5D1993C897E5.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 1,985,000,000 United States dollar | superseded | [clm_5F7FEF1048F8](/claim/clm_5F7FEF1048F8.md)
- 2023-12-31 to 2024-03-31 | total_assets | 21,620,000,000 United States dollar | superseded | [clm_FA78180A8490](/claim/clm_FA78180A8490.md)

## 2024

- 2024-02-16 | board_member | Zane Rowe | valid | [clm_77B3D67ED270](/claim/clm_77B3D67ED270.md)
- 2024-02-23 to 2024-04-29 | shares_outstanding | 518,000,000 shares | superseded | [clm_9B1054D5983C](/claim/clm_9B1054D5983C.md)
- 2024-03-31 to 2024-06-30 | total_assets | 21,418,000,000 United States dollar | superseded | [clm_05348D625F89](/claim/clm_05348D625F89.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | 631,000,000 United States dollar | superseded | [clm_21E8AA500382](/claim/clm_21E8AA500382.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 2,556,000,000 United States dollar | superseded | [clm_8927195C361D](/claim/clm_8927195C361D.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 2,130,000,000 United States dollar | superseded | [clm_977D4DAAACBD](/claim/clm_977D4DAAACBD.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 438,000,000 United States dollar | superseded | [clm_9B356D2B270B](/claim/clm_9B356D2B270B.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 351,000,000 United States dollar | superseded | [clm_AFA56D993705](/claim/clm_AFA56D993705.md)
- 2024-03-31 to 2024-06-30 | total_equity | 6,273,000,000 United States dollar | superseded | [clm_C8F51679367B](/claim/clm_C8F51679367B.md)
- 2024-04-29 to 2024-05-24 | shares_outstanding | 506,000,000 shares | superseded | [clm_1000D6B3084D](/claim/clm_1000D6B3084D.md)
- 2024-05-24 to 2024-07-26 | shares_outstanding | 502,000,000 shares | superseded | [clm_ACE5936A9C4A](/claim/clm_ACE5936A9C4A.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 379,000,000 United States dollar | superseded | [clm_21793C6479C8](/claim/clm_21793C6479C8.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | 549,000,000 United States dollar | superseded | [clm_A7749EF78878](/claim/clm_A7749EF78878.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 2,572,000,000 United States dollar | superseded | [clm_AC850B7412AE](/claim/clm_AC850B7412AE.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | 224,000,000 United States dollar | superseded | [clm_C89AB0CFE4C4](/claim/clm_C89AB0CFE4C4.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 1,963,000,000 United States dollar | superseded | [clm_D955EF027C4A](/claim/clm_D955EF027C4A.md)
- 2024-06-30 to 2024-09-30 | total_equity | 5,525,000,000 United States dollar | superseded | [clm_DB07E1DA8E96](/claim/clm_DB07E1DA8E96.md)
- 2024-06-30 to 2024-09-30 | total_assets | 20,378,000,000 United States dollar | superseded | [clm_EA80039AE5AF](/claim/clm_EA80039AE5AF.md)
- 2024-07-26 to 2024-10-25 | shares_outstanding | 489,000,000 shares | superseded | [clm_384B7E8CCD21](/claim/clm_384B7E8CCD21.md)
- 2024-09-18 | board_member | William D. Nash | valid | [clm_7E5AD6E0F52A](/claim/clm_7E5AD6E0F52A.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 1,589,000,000 United States dollar | superseded | [clm_0BF628343E0D](/claim/clm_0BF628343E0D.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 634,000,000 United States dollar | superseded | [clm_31DA812746B4](/claim/clm_31DA812746B4.md)
- 2024-09-30 to 2024-12-31 | total_equity | 5,420,000,000 United States dollar | superseded | [clm_3291FAD475EA](/claim/clm_3291FAD475EA.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | 595,000,000 United States dollar | superseded | [clm_382743279B70](/claim/clm_382743279B70.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 2,576,000,000 United States dollar | superseded | [clm_3CD5E1A02ACB](/claim/clm_3CD5E1A02ACB.md)
- 2024-09-30 to 2024-12-31 | total_assets | 19,915,000,000 United States dollar | superseded | [clm_6F105301C9FF](/claim/clm_6F105301C9FF.md)
- 2024-10-25 to 2025-02-21 | shares_outstanding | 479,000,000 shares | superseded | [clm_9802A5F72816](/claim/clm_9802A5F72816.md)
- 2024-12-31 to 2025-12-31 | net_income | 1,975,000,000 United States dollar | superseded | [clm_11E74611F453](/claim/clm_11E74611F453.md)
- 2024-12-31 to 2025-03-31 | total_assets | 19,365,000,000 United States dollar | superseded | [clm_1261DCB3AC43](/claim/clm_1261DCB3AC43.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 1,479,000,000 United States dollar | superseded | [clm_AEB054FDBB66](/claim/clm_AEB054FDBB66.md)
- 2024-12-31 to 2025-03-31 | total_equity | 5,158,000,000 United States dollar | superseded | [clm_AF092373BB91](/claim/clm_AF092373BB91.md)
- 2024-12-31 to 2025-12-31 | operating_income | 2,318,000,000 United States dollar | superseded | [clm_BD60EA86C41C](/claim/clm_BD60EA86C41C.md)
- 2024-12-31 to 2025-12-31 | revenue | 10,283,000,000 United States dollar | superseded | [clm_D28F7136D53F](/claim/clm_D28F7136D53F.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 2,433,000,000 United States dollar | superseded | [clm_F6CA304074D4](/claim/clm_F6CA304074D4.md)

## 2025

- 2025-02-21 to 2025-04-28 | shares_outstanding | 466,000,000 shares | superseded | [clm_4FC36007BF1E](/claim/clm_4FC36007BF1E.md)
- 2025-03-31 to 2025-06-30 | total_assets | 18,954,000,000 United States dollar | superseded | [clm_04FA094021E0](/claim/clm_04FA094021E0.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 3,031,000,000 United States dollar | superseded | [clm_0D1943720341](/claim/clm_0D1943720341.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | 503,000,000 United States dollar | superseded | [clm_1AB8DC5C78EF](/claim/clm_1AB8DC5C78EF.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 362,000,000 United States dollar | superseded | [clm_9C1098FA3F53](/claim/clm_9C1098FA3F53.md)
- 2025-03-31 to 2025-06-30 | total_equity | 4,950,000,000 United States dollar | superseded | [clm_A8473BC72089](/claim/clm_A8473BC72089.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | 616,000,000 United States dollar | superseded | [clm_ACFEE09624C2](/claim/clm_ACFEE09624C2.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 2,585,000,000 United States dollar | superseded | [clm_B8E8C07CC8DE](/claim/clm_B8E8C07CC8DE.md)
- 2025-04-28 to 2025-05-26 | shares_outstanding | 461,000,000 shares | superseded | [clm_D578DC8CBBDD](/claim/clm_D578DC8CBBDD.md)
- 2025-05-12 | cfo | Peggy Alford | valid | [clm_8C5335039D1C](/claim/clm_8C5335039D1C.md)
- 2025-05-26 to 2025-07-25 | shares_outstanding | 461,000,000 shares | superseded | [clm_439DF92FFD56](/claim/clm_439DF92FFD56.md)
- 2025-06-30 to 2025-09-30 | total_assets | 17,961,000,000 United States dollar | superseded | [clm_03B232A27C01](/claim/clm_03B232A27C01.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 2,730,000,000 United States dollar | superseded | [clm_558A0A4EBA20](/claim/clm_558A0A4EBA20.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | 484,000,000 United States dollar | superseded | [clm_65BB5F6B4A23](/claim/clm_65BB5F6B4A23.md)
- 2025-06-30 to 2025-09-30 | total_equity | 4,749,000,000 United States dollar | superseded | [clm_7920A63E3553](/claim/clm_7920A63E3553.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 421,000,000 United States dollar | superseded | [clm_AC6E031A58B7](/claim/clm_AC6E031A58B7.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 2,070,000,000 United States dollar | superseded | [clm_D43014F37A3C](/claim/clm_D43014F37A3C.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | 368,000,000 United States dollar | superseded | [clm_D4E5FA305A2C](/claim/clm_D4E5FA305A2C.md)
- 2025-07-25 to 2025-10-24 | shares_outstanding | 457,000,000 shares | superseded | [clm_ECF609E20919](/claim/clm_ECF609E20919.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 2,423,000,000 United States dollar | superseded | [clm_25C833FC304A](/claim/clm_25C833FC304A.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 423,000,000 United States dollar | superseded | [clm_5BE27668B33E](/claim/clm_5BE27668B33E.md)
- 2025-09-30 to 2025-12-31 | total_equity | 4,719,000,000 United States dollar | superseded | [clm_952FD64E9ACE](/claim/clm_952FD64E9ACE.md)
- 2025-09-30 to 2025-12-31 | total_assets | 17,791,000,000 United States dollar | superseded | [clm_DA01170A43AD](/claim/clm_DA01170A43AD.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 632,000,000 United States dollar | superseded | [clm_E3D96151D45A](/claim/clm_E3D96151D45A.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | 576,000,000 United States dollar | superseded | [clm_E7F08D7CA437](/claim/clm_E7F08D7CA437.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 2,820,000,000 United States dollar | superseded | [clm_FC0FBDA44E4C](/claim/clm_FC0FBDA44E4C.md)
- 2025-10-24 to 2026-02-13 | shares_outstanding | 452,000,000 shares | superseded | [clm_B93643A0AE72](/claim/clm_B93643A0AE72.md)
- 2025-12-31 | employees | 12,300 | valid | [clm_140CE727D112](/claim/clm_140CE727D112.md)
- 2025-12-31 | operating_income | 2,277,000,000 United States dollar | valid | [clm_2AEEBAD87634](/claim/clm_2AEEBAD87634.md)
- 2025-12-31 to 2026-03-31 | total_assets | 17,610,000,000 United States dollar | superseded | [clm_4B0BE0B91AED](/claim/clm_4B0BE0B91AED.md)
- 2025-12-31 | revenue | 11,100,000,000 United States dollar | valid | [clm_5698A8F5890B](/claim/clm_5698A8F5890B.md)
- 2025-12-31 | research_and_development | 1,642,000,000 United States dollar | valid | [clm_8D23B652F896](/claim/clm_8D23B652F896.md)
- 2025-12-31 to 2026-03-31 | total_equity | 4,615,000,000 United States dollar | superseded | [clm_B912F2B1D781](/claim/clm_B912F2B1D781.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,867,000,000 United States dollar | superseded | [clm_CB08E43954BC](/claim/clm_CB08E43954BC.md)
- 2025-12-31 | net_income | 2,031,000,000 United States dollar | valid | [clm_EE73F84E5956](/claim/clm_EE73F84E5956.md)

## 2026

- 2026-02-13 to 2026-04-24 | shares_outstanding | 448,000,000 shares | superseded | [clm_A42EEA17D7B7](/claim/clm_A42EEA17D7B7.md)
- 2026-03-20 | board_member | Brian H. Sharples | valid | [clm_7F971A7A67C1](/claim/clm_7F971A7A67C1.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 512,000,000 United States dollar | superseded | [clm_0A080275CB75](/claim/clm_0A080275CB75.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 2,894,000,000 United States dollar | superseded | [clm_24831B9B68EB](/claim/clm_24831B9B68EB.md)
- 2026-03-31 to 2026-06-30 | total_equity | 4,412,000,000 United States dollar | superseded | [clm_6EAF4EFEB795](/claim/clm_6EAF4EFEB795.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 3,089,000,000 United States dollar | superseded | [clm_8EA1FED01B8B](/claim/clm_8EA1FED01B8B.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 611,000,000 United States dollar | superseded | [clm_9A5DF0E1C15B](/claim/clm_9A5DF0E1C15B.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 450,000,000 United States dollar | superseded | [clm_CAF51C38CF56](/claim/clm_CAF51C38CF56.md)
- 2026-03-31 to 2026-06-30 | total_assets | 17,893,000,000 United States dollar | superseded | [clm_E04BE818BF88](/claim/clm_E04BE818BF88.md)
- 2026-04-24 to 2026-07-31 | shares_outstanding | 444,000,000 shares | superseded | [clm_6D94773E651E](/claim/clm_6D94773E651E.md)
- 2026-06-30 | quarterly_net_income | 550,000,000 United States dollar | valid | [clm_075EADC84317](/claim/clm_075EADC84317.md)
- 2026-06-30 | quarterly_operating_income | 676,000,000 United States dollar | valid | [clm_141F3AC5BA83](/claim/clm_141F3AC5BA83.md)
- 2026-06-30 | quarterly_research_and_development | 484,000,000 United States dollar | valid | [clm_1EDA9E9B0B69](/claim/clm_1EDA9E9B0B69.md)
- 2026-06-30 | cash_and_equivalents | 2,310,000,000 United States dollar | valid | [clm_9E25B9299149](/claim/clm_9E25B9299149.md)
- 2026-06-30 | total_equity | 4,665,000,000 United States dollar | valid | [clm_A1AF462445F5](/claim/clm_A1AF462445F5.md)
- 2026-06-30 | total_assets | 17,933,000,000 United States dollar | valid | [clm_CCD50EAEE21D](/claim/clm_CCD50EAEE21D.md)
- 2026-06-30 | quarterly_revenue | 3,134,000,000 United States dollar | valid | [clm_F419BE69599B](/claim/clm_F419BE69599B.md)
- 2026-07-31 | shares_outstanding | 445,000,000 shares | valid | [clm_3B9BF72773A9](/claim/clm_3B9BF72773A9.md)
- 2026-10-20 | restructuring | Plan to reduce global workforce by approximately 9% with exit charges. | valid | [clm_42ADB0C0A60C](/claim/clm_42ADB0C0A60C.md)
- 2026-10-28 | market_cap | 52,100,000,000 United States dollar | unverified | [clm_8170725E3D04](/claim/clm_8170725E3D04.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.